Front. Nutr. Frontiers in Nutrition Front. Nutr. 2296-861X Frontiers Media S.A. 10.3389/fnut.2022.746881 Nutrition Review Chemistry and Pharmacological Actions of Delphinidin, a Dietary Purple Pigment in Anthocyanidin and Anthocyanin Forms Husain Asif 1 Chanana Harshit 1 Khan Shah Alam 2 Dhanalekshmi U. M. 2 Ali M. 3 Alghamdi Anwar A. 4 Ahmad Aftab 4 * 1Department of Pharmaceutical Chemistry, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi, India 2College of Pharmacy, National University of Science and Technology, Muscat, Oman 3Department of Pharmacognosy, College of Pharmacy, Jazan University, Jizan, Saudi Arabia 4Department of Health Information Technology, Faculty of Applied Studies, King Abdulaziz University, Jeddah, Saudi Arabia

Edited by: Márcio Carocho, Centro de Investigação de Montanha (CIMO), Portugal

Reviewed by: Adilson Alves De Freitas, University of Lisbon, Portugal; Michael Erich Netzel, The University of Queensland, Australia

 *Correspondence: Aftab Ahmad aftab786sa@hotmail.com; abdulsalam@kau.edu.sa

This article was submitted to Food Chemistry, a section of the journal Frontiers in Nutrition

 17 03 2022 2022 9 746881 25 07 2021 31 01 2022 Copyright © 2022 Husain, Chanana, Khan, Dhanalekshmi, Ali, Alghamdi and Ahmad. 2022 Husain, Chanana, Khan, Dhanalekshmi, Ali, Alghamdi and Ahmad

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

Anthocyanins are naturally occurring water-soluble flavonoids abundantly present in fruits and vegetables. They are polymethoxyderivatives of 2-phenyl-benzopyrylium or flavylium salts. Delphinidin (Dp) is a purple-colored plant pigment, which occurs in a variety of berries, eggplant, roselle, and wine. It is found in a variety of glycosidic forms ranging from glucoside to arabinoside. Dp is highly active in its aglycone form, but the presence of a sugar moiety is vital for its bioavailability. Several animal and human clinical studies have shown that it exerts beneficial effects on gut microbiota. Dp exhibits a variety of useful biological activities by distinct and complex mechanisms. This manuscript highlights the basic characteristics, chemistry, biosynthesis, stability profiling, chemical synthesis, physicochemical parameters along with various analytical methods developed for extraction, isolation and characterization, diverse biological activities and granted patents to this lead anthocyanin molecule, Dp. This review aims to open pathways for further exploration and research investigation on the true potential of the naturally occurring purple pigment (Dp) in its anthocyanidin and anthocyanin forms beyond nutrition.

 Graphical Abstract

delphinidin anthocyanidin anthocyanin health benefits bioavailability 578-156-1442 King Abdulaziz University10.13039/501100004054

香京julia种子在线播放

    • <form id=HxFbUHhlv><nobr id=HxFbUHhlv></nobr></form>
      <address id=HxFbUHhlv><nobr id=HxFbUHhlv><nobr id=HxFbUHhlv></nobr></nobr></address>

      

Highlights


      - It covers phytochemistry of delphinidin including biosynthesis, extraction, isolation, and analysis.
      

      - Overview of biological activities of delphinidin and its glycosides with emphasis on molecular mechanism.
      

      - It lists synergistic combinations of delphinidin with anticancer agents.
      

      - It includes patents granted to delphinidin.
      
      

Introduction

      Flavonoids are one of the biggest classes of polyphenolic compounds having diverse chemical structures and characteristics that are present ubiquitously in plants. These plant pigments have a skeleton of 15 carbon atoms (C6-C3-C6) containing three rings, viz., 2 phenolic (A, B) and one pyran (C) rings (Figure 1) (1). The first classical report on isolation of blue anthocyanin from Centaurea cyanus (cornflower) was published in 1913 by Willstätter and Everest (2).
      



      Major anthocyanins and glycosidic forms of delphinidin present in nature.
      

      

      Anthocyanins (anthos means flower and kyanos means blue in Greek) belong to a class of water-soluble flavonoids and are natural pH indicators (3). They are commonly found in higher plants and are mainly accountable for the blue, purple, and red colors of fruits like berries, grapes, currants (gooseberries), some tropical fruits, vegetables, roots, and cereals. Acyl glycosides of anthocyanidin are biosynthesized via the phenylpropanoid pathway (4). Chemically, these compounds are polymethoxy or polyhydroxy derivatives of flavylium or 2-phenyl-benzopyrylium salts. Glycosidic moieties are present as mono-, di-, or triglycerides bonded by α or β glycosidic linkages. Glycosidic linkage is present in the C-3 position of the anthocyanidin (aglycone). Commonly present sugar moieties include glucose, galactose, rhamnose, arabinose, and xylose (5). The sugar part (glycone) of anthocyanins is responsible for chemical stability and solubility. Anthocyanin content in fruits and vegetables varies considerably and is found in the range of ~30–1,500 mg/100 g (6). An anthocyanidin is an aglycone moiety that is formed by hydrolysis of anthocyanin glycoside. Anthocyanins are ingested as components of complex mixtures of flavonoid components. Presence of flavylium ion and unusual electron distribution make anthocyanidins a highly unstable moiety; hence, the aglycone form of anthocyanins exists very rarely in nature (7).
      

      Approximately, over 700 unique anthocyanins have been isolated so far (8). Most abundant anthocyanin aglycones (anthocyanidins) include peonidin (Pn), cyanidin (Cy), perlargonidin (Pg), malvidin (Mv), petunidin (Pt), and delphinidin (Dp), and they are of paramount importance. Anthocyanins are commonly used in food supplements and nutraceuticals because of their beneficial effects on humans. Anthocyanins exhibit a broad range of pharmacological activities, and they have antioxidant, anti-inflammatory (9), anticancer (10), anti-ulcer (11), cardioprotective (12), antidiabetic (13), and neuroprotective (14) properties. Anthocyanins are differentiated on the basis of number and nature of aliphatic or aromatic acids attached to sugars in a molecule, degree of methylation of hydroxyl groups, number of hydroxyl groups present, and nature, number, and location of sugars attached to a molecule (15). Conjugated double bonds present in an anthocyanidin moiety are responsible for absorption of light and production of unique colors. In general, methoxylation in an aromatic ring imparts a red color while increase in hydroxylation tends to make a pigment blue. In anthocyanidins, chief structural differences occur in the 3′ and 5′ positions of a B ring. Glycosides of Cy, Dp, and Pg are extensively distributed in nature. The distribution of Dp in edible plant parts is around 12% (16). Copious concentrations of Dp are present in blue and purple flowers, and Dp is biosynthesized along with Pg and Cy; principally, these are basic anthocyanidin skeletons of flower color pigments (17). Dp is a magenta- to purple-colored plant pigment and a dominant anthocyanidin found in blackcurrant, bilberry, blueberry, concord grape, eggplant, roselle, and wine (18). Chemical structures of some major and therapeutically important anthocyanidins are given in Figure 1 (7).
      

      Dp (3,3',4',5,5',7-hexa-hydroxy-flavylium), one of the major anthocyanidins, is a polyphenolic compound with oxygen in the 1st position, and is linked to the sugar moiety in 3-O-β- position of the C ring. Dp (PubChem CID: 68245) is made up of three rings, viz, A (resorcinol), B (catechol), and C (3-O-subsituted-pyrylium). Dp has 6 hydrogen bond donor and 6 hydrogen bond acceptor atoms. Because of the presence of numerous electron donor atoms, Dp acts as a potent antioxidant by scavenging reactive oxygen species (ROS). The presence of a 3-hydroxyl group in ring B of Dp distinguishes it from other anthocyanins. It also possesses two hydroxy groups in ring A. These -OH groups are responsible for a variety of crucial biological activities, as they form potent interactions with a variety of proteins (19). Dp is more active in its aglycone form, but the presence of a sugar moiety in the 3rd position of the C ring is vital for its bioavailability (20). Dp is highly polar compared to most of anthocyanins owing to the presence of several hydroxyl groups and, thus, is easily soluble in methanol and water (21). Dp is linked to a variety of sugar moieties, ranging from glucoside to arabinoside in the C-3 position. Some major glycosidic forms of Dp present in nature are illustrated in Figure 1.
      

      There has been a substantial increase in the frequency of publication of articles stipulating the therapeutic effectiveness of Dp and its glycosides over the years. This review article aimed to discuss the phytochemical aspects, biosynthesis, physiochemical characteristics, and potential therapeutic activities of Dp, and the progress made in research on this purple pigment and its glycosides.
      

Phytochemical Aspects of Dp

Biosynthesis

      Delphinidin (Dp) is biosynthesized along with other anthocyanidins (Cy and Pg) from coumaroyl-CoA and malonyl-CoA (Figure 2), and 3',5'-hydroxylase is the key enzyme for Dp biosynthesis (22, 23). De novo assembly method used for biosynthesis of anthocyanin includes cinnamate-4-hydroxylase gene (C4H) and Chalcone synthase gene (CHS) and unigenes (24–26).
      



      Biosynthetic pathway of delphinidin. ANS, anthocyanidin synthase; CHS, chalcone synthase; CHI, chalcone isomerase; F3H, flavanone 3-hydroxylase; F3′H, flavonoid-3′5′-hydroxylase; F3′5′H, flavonoid-3′,5′-hydroxylase; DFR, dihydroflavonol-4-reductase; UF3GT, UDP-Glc flavonoid 3-O-glucosyl transferase.
      

      

      Delphinidin (Dp) is responsible for the magenta, purple, and blue colors of flowers. Dp, after biosynthesis, is glycosylated, acetylated, and methylated by glucosyltransferases, acyltransferases, and methyltransferases, respectively. Glycosylation of Dp takes place in the 3rd position. Methylation of Dp (anthocyanin) takes place in the 3' and 5' positions, resulting in formation of other anthocyanins (Pt and Mv) (27). UFGT and reductase enzymes compete to form anthocyanins and proanthocyanidins, respectively. Dp and leucodelphinidin undergo enzymatic reduction to epigallocatechin and gallocatechin, respectively. Following reduction, both epigallocatechin and gallocatechin or catechin (formed from leucocyanidin) undergo polymerization to form prodelphinidin. The enzyme responsible for polymerization is still unknown. Prodelphinidin is biosynthesized along with procyanidin (28).
      

      Inspection of major metabolic pathways via chemical and transcriptomics analyses on Dp shows mutation of the ScbHLH17 and ScHI1/2 coding regions of anthocyanin formation in white yellow cultivars (29). Dp derivative-expressed ANS, F3'H, and DFR, genes have been determined by real-time quantitative (RT-q)PCR (30). Free anthocyanins in grapes are synthesized by the flavonoid pathway, which takes the similar upstream pathway with pro-anthocyanidins until formation of anthocyanins by catalysis of anthocyanidin synthase, also known as leucoanthocyanidin dioxygenase (7). On inspecting the mechanism of pre-harvest and post-harvest, UV showed pre-harvest UV-B, C and post-harvest UV-A, B, C irradiation lead to substantial anthocyanin biosynthesis in blueberry (31). Various metabolites identified by HPLC-MS specified that anthocyanin biosynthesis in purple-colored leaves was augmented, with maximum concentration of anthocyanidins, pro-anthocyanidins, and kaempferol glycoside (32). The biosynthetic pathway of Dp is outlined in Figure 2.
      

Chemical Synthesis

      Pratt and Robinson (33), first proposed the scheme for synthesis of various anthocyanins such as Dp (Figure 3A). Biosynth AS, on behalf of Bakstad et al. (34). filed a patent (US8513395B2) for anthocyanin synthesis in 2006, and the patent was granted in August 2013. Thiele et al. (35), proposed a method for synthesis of Dp (Figure 3B), which produced better yield and purity of Dp chloride than the scheme proposed by Kraus et al. (36). Synthesis of light-independent and light-inducible anthocyanins controlled by specified genes in grape was introduced by Ma et al. (37).
      



      (A,B) Synthesis of delphinidin chloride.
      

      

Stability Profile

      It is known that various chemical and environmental factors such as temperature, pH, light, and air affect the stability of anthocyanins, leading to easy degradation and decomposition during processing and storage (38). Anthocyanins degrade faster with increase in temperature. Dp, upon thermal degradation, undergoes B ring opening to produce an intermediate Dp chalcone by a first-order reaction. Dp chalcone further decomposes to produce 3,4,5 trihydroxybenzoic acid and phloroglucinaldehyde through B ring-retained and A ring-retained cleavages, respectively. Among various thermal degradation methods, HPLC-Q-TOF-MS analysis indicated that microwave causes highest rate of degradation as Dp content reduced from 100 to 43.2% in just 10 s followed by conventional heating and then ultrasound treatment. Trauner provided the first report regarding pH-dependent color change in anthocyanins (2). Dp is highly stable under acidic conditions but unstable in alkaline and neutral pH. Stability of Dp can be related to the presence of three-OH groups on ring B. The blue tinge in flowers is due to the presence of Dp pigment under alkaline conditions (39). Dp is a natural pH indicator, and it appears red in acidic pH, blue in basic pH, and purple to magenta in neutral pH (23). The color of Dp pigment is purple because substitution of the three hydroxyl groups on ring B that results in bathochromic shift of visible absorption maximum (λmax) to a longer wavelength (17). Nanogel encapsulation enhances the chemical stability of cyanidin-3-O-glucoside (Cy3G) by combining Maillard reaction and heat gelation (40, 41). Flavone co-pigments resulted in hyperchromic and bathochromic shifts, and a protective effect of flavone co-pigmentation was found in glycosides (42). Anthocyanins, cyanidin 3-O-β-rutinoside (Cy-3R), and cyanidin 3-O-β-glucoside displayed first-order degradation rates, presenting higher size of conjugated sugars (43). For interpretation of the absence of color phenotype in white-colored flowers of strawberry hybrids, a new hypothesis was pressed based on transcriptome analysis and the competitive effect of FpFLS and FpDFR genes that were shown to inhibit anthocyanin synthesis (44). The pH-mediated degradation pathway for Dp is illustrated in Figure 4.
      



      pH-mediated degradation of delphinidin: in low pH, 1–2 red colored flavylium cations are observed, in alkaline pH 8–10 blue-color quinonoidal bases, in pH 4–6 colorless carbinol pseudobase and chalcone, and in pH > 7, degradation products of delphinidin, 2,4,6-trihydroxybenzaldehyde and gallic acid, are observed (45, 46).
      

      

Physicochemical Aspects

      Dp is highly soluble in polar solvents, and it increases with increase in temperature and polarity. The mole fraction solubility of Dp is highest in methanol (58.61 ± 0.01 to 168.64 ± 0.02) followed by water (53.53 ± 0.06 to 163.71 ± 0.02), ethanol (5.73 ± 0.02 to 15.59 ± 0.02), and acetone (0.0055 ± 0.0012 to 0.0157 ± 0.0013) at temperatures ranging from 298.15 to 343.15 K (21). Because of high polarity, Dp possesses low logP-values, which results in poor lipid solubility. Lipid solubility can be ameliorated by lipophilization of Dp. Márquez-Rodríguez et al. carried out lipophilization of Dp-3-S extracted from Hibiscus sabdariffa using octanoyl chloride. Three ester derivatives of Dp-3-S were prepared by subsequent esterification in the C-4' position of ring B of Dp moiety, C-4' and sambubioside moiety, and sambubioside moiety, respectively. Results evaluated by density functional theory demonstrated esterification of the sambubioside (sugar) moiety to yield the most fruitful results. It resulted in high solubility in lipophilic medium without interfering with physical properties of Dp, as lipophilization of the sugar moiety averts the loss of absorbance intensity and its excited states are same with its precursor, Dp-3-S (47). Glycosides of Dp showed poor stability profile compared to other anthocyanins (Cy, Pt, Pn, and Mv) because of the number of -OH groups in the B ring, whereas methoxy group substitution in ring B augmented the stability as in Pt, Pn, and Mv. Furthermore, Dp-3G was stable under gastric (acidic) conditions but presented poor stability under intestinal (basic) conditions (48).
      

Extraction, Isolation, and Characterization

      Earlier, anthocyanins were extracted with a traditional solvent-aided extraction method using alcohol and acid (4). Newer anthocyanin extraction techniques have been introduced like super critical fluid chromatography (SCFC) (49), ultrasound-aided extraction (50), microwave-aided extraction (51), accelerated solvent extraction (52), enzyme-aided extraction (53), and solid-phase extraction (54).
      

      Dp is isolated and characterized by numerous chromatographic and spectroscopic techniques such as high-speed countercurrent chromatography (55), ionic liquid-modified countercurrent chromatography, partition chromatography (56), HPLC-ESI/MS (57), and NMR (50, 58). High-performance liquid chromatography-mass spectrometry (HPLC-MS) and liquid chromatography-tandem mass spectrometry (LC-MS/MS) are two of the most important hyphenated analytical methods practiced for qualitative and quantitative analyses of Dp. A general description of extraction, isolation, analysis, and characterization of Dp from various sources is presented in Table 1.
      



      Conditions required for extraction, isolation, and characterization of delphinidin and its glycosides.
      

      

      
S. No.
Plant products containing Dp as the major anthocyanin
Method for extraction of anthocyanin
Analysis and characterization of anthocyanins
Concentration of Dp glycosides
References

      
      


      
1
Highbush blueberry (Vaccinium corymbosum L.)
Solvent aided extraction using acetone and acetic acid (99:1 v/v) and further ultrasound assisted sonification for 15 min
HPLC conditions column: Zorbax SB-C18 column (50 × 4.6 mm, 5 μm)Flow rate: 0.4 mL/minMobile phase A: 5% formic acid solutionMobile phase B: methanolInjection volume: 10 μLDAD wavelength: 190–600 nmESI-MS
Toro speciesDp-3-Ga: 7.68 ± 1.42 mg/100 gDp-3-A: 1.63 ± 0.09 mg/100 gLegacy speciesDp-3-Ga: 11.44 ± 3.70 mg/100 gDp-3-A: 4.07 ± 1.15 mg/100 gDuke speciesDp-3-Ga: 14.99 ± 3.97 mg/100 gDp-3-A: 5.10 ± 1.22 mg/100 gBluecrop speciesDp-3-Ga: 2.29 ± 0.21 mg/100 gDp-3-G: 1.21 ± 0.10 mg/100 gDp-3-A: 1.66 ± 0.10 mg/100 g
(59)

      

      
2
Highbush blueberry (Vaccinium corymbosum L.)
Solvent assisted extraction with 87% v/v acetonitrile, 3% v/v water, 10% v/v formic acid from blueberry and its juice
HPLC conditions column: Phenomenex Luna C-18, 100A (250 × 4.60 mm, 3μ)Column temperature: 25°CFlow rate: 0.5 mL/minMobile phase A: 87% v/v acetonitrile, 3% v/v water, 10% v/v formic acidMobile phase B: 50% v/v acetonitrile, 40% v/v water, 10% v/v formic acidDAD wavelength: 520 nm
Blueberry from UruguayAnthocyanins: 1,570 mg/100 g dry weightDp-3-Ga: 298 mg/100 gDp-3-G: 128 mg/100 gDp-3-A: 142 mg/100 gBlueberry from PolandAnthocyanins: 2,242 mg/100 gDp-3-Ga: 541 mg/100 gDp-3-G: 11 mg/100 gDp-3-A: 244 mg/100 gBlueberry from GermanyAnthocyanins: 2,762 mg/100 gDp-3-Ga: 543 mg/100 gDp-3-G: 12 mg/100 gDp-3-A: 250 mg/100 g
(60)

      

      
3
Lowbush blueberry (Vaccinium angustifolium)
Solvent assisted extraction carried using acidified ethanol and then further extracted by solid phase extraction carried out using Circa, C-18 adsorbent (modified silica gel distribution of particles 40–63 um, organic load 0.38 mmol g−1, carbon load 9.16%) dispersed in 95% ethanol
Preparative HPLC conditions column: XTerra Prep MS C-18 OBDTM (5 mm, 19 × 100 mm i.d., 5 μm)Column temperature: 25°CFlow rate: 2.0 mL/minMobile phase A: 5% formic acid solutionMobile phase B: MethanolDAD wavelength: 520 nm
Anthocyanin: 485 mg of cyanin equivalentDp-3-Ga: 16 mg of cyanin equivalentDp-3-G: 31 mg of cyanin equivalentDp-3-Ar: 19 mg of cyanin equivalentDp-3-(p-coumaroyl)-G: 5 mg of cyanin equivalentDp-3-(6″-acetyl)-G: 20 mg of cyanin equivalent
(61)

      

      
4
Lowbush blueberry (Vaccinium angustifolium)
Solid phase extraction using (SPE)-cartridge (Strata-X 300 mg/3 mL, Phenomenex) and elution was carried out using 0.01 N HCl (5 mL), ethyl acetate (10 mL), and acidified methanol (5 mL) with 0.1% HCl
HPLC conditions column: C-18 Kinetex column (150 × 4.6 mm, 2.6 μm)Column temperature: 45°CFlow rate: 1.7 mL/minMobile phase A: 1 % H3PO4Mobile phase B: acetonitrile/water (35:65 v/v)DAD wavelength: 200–700 nm, Anthocyanin (520 nm)
Anthocyanin: 29.9 ± 5.17 mg/mLDp-3-G: 2.18 ± 0.7 mg/mLDp-3-GA: 1.55 ± 0.15 mg/mLDp-3-A: 0.75 ± 0.02 mg/mL
(62)

      

      
5
Bilberry (Vaccinium myrtillus L.)
Solvent aided extraction using ethyl acetate and maceration with acidified methanol (0.6 M HCl) to extract anthocyanin
HPLC conditions column: Zorbax SB-C-18 column (150 × 4.6 mm i.d., 5 um)Column temperature: 25°CFlow rate: 1.0 ml/minInjection volume: 5 ul
Anthocyanins: 568.8 ± 8.8 mg/100 g fresh weightDp-3-Ga: 92.1 ± 4.7 mg/100 gDp-3-G: 86.6 ± 10.5 mg/100 gDp-3-A: 59.1 ± 4.8 mg/100 g
(63)

      

      



Mobile phase A: water–formic acid (9:1 v/v)Mobile phase B: methanol-water-formic acid(5:4:1 v/v/v)DAD wavelength: 190–650 nmESI+/MS & MS2 conditions



      

      
6
Bilberry (Vaccinium myrtillus L.)
Solvent assisted extraction with 87% v/v acetonitrile, 3% v/v water, 10% v/v formic acid from blueberry and its juice
HPLC conditions column: Phenomenex Luna C-18, 100A (250 × 4.60 mm, 3 μm)Column temperature: 25°CFlow rate: 0.5 mL/minMobile phase A: 87% v/v acetonitrile, 3% v/v water, 10% v/v formic acidMobile phase B: 50% v/v acetonitrile, 40% v/v water, 10% v/v formic acidDAD wavelength: 520 nm
Bilberry from Poland (sample I)Anthocyanin: 6,102 mg/100g dry weightDp-3-Ga: 847 mg/100 gDp-3-G: 1,047 mg/100 gDp-3-A: 603 mg/100 gBilberry from Poland (sample II)Anthocyanin: 7,465 mg/100 gDp-3-Ga: 1,060 mg/100 gDp-3-G: 1,247 mg/100 gDp-3-A: 741 mg/100 g
(60)

      

      
7
Bilberry (Vaccinium myrtillus L.)
Extraction carried out using 60% ethanol acidified with HClPurification by macroporous adsorbent (Amberlite XAD-7, XAD-4, AB-8, ADS-17, and DE- 5-40)
HPLC conditions column: Venusil ASB C18 (250 × 4.6 mm, 5 μm)Column temperature: 30°CFlow rate: 1 mL/minMobile phase A: anhydrous formic acid/water (8.5:91.5 v/v)Mobile phase B: anhydrous formic acid/acetonitrile/methanol/water (8.5:22.5:22.5:41.5 v/v/v/v)DAD wavelength: 535 nm
ND
(64)

      

      
8
Blackcurrant (Ribes nigrum L.)
Solvent aided extraction using acetone and acetic acid (99:1 v/v) and further ultrasound assisted sonification for 15 min
HPLC conditions column: Zorbax SB-C18 column (50 × 4.6 mm, 5 μm)Flow rate: 0.4 mL/minMobile phase A: 5% formic acid solutionMobile phase B: methanolInjection volume: 10 μLGradient conditions: 5% B (5 min), 5–50% B (45 min), 50–75% B (55 min), 75–100% B (65 min)DAD wavelength: 190–600 nmESI+/-/MS3 conditions capillary voltage: 3,100 VCapillary temperature: 325°CNebulizing gas (N2) pressure: 50 psiNebulizing gas (N2) flow rate: 12 L/minCollision gas (He) voltage ramping cycle: 0.3–2 V
Rosenthal speciesAnthocyanin: 180.44 ± 3.59 mg/100gDp-3-G: 16.86 ± 4.07 mg/100gDp-3-R: 89.66 ± 8.33 mg/100gRovada speciesAnthocyanin: 162.83 ± 2.46Dp-3-G: 13.92 ± 7.33 mg/100 gDp-3-R: 65.27 ± 25.39 mg/100 g
(59)

      

      
9
Blackcurrant (Ribes nigrum L.) pomace
Extraction with methanol:water:formic acid (50:48:2 v/v/v)
HPLC conditions column: Gemini 5u C-18 110A column (150 × 4.6 mm i.d., 5 μm)Column temperature: 40°CFlow rate: 1 mL/minInjection volume: 20 μlMobile phase A: 10% v/v formic acid solutionMobile phase B: acetonitrile:water:formic acid (50:40:10 v/v/v)DAD wavelength: 520 nm
Anthocyanin content from two harvest seasons (2006–2007) fraction 0.8Anthocyanin-344.6 ± 0.5–729.7 ± 4.4 mg/100 gDp-3-G: 85.3 ± 1.2–190.9 ± 0.3 mg/100 gDp-3-R: 122.2 ± 1.7–254.2 ± 3.4 mg/100 gFraction 2–5Anthocyanin: 577.1 ± 32.2–1,046.1 ± 10.4 mg/100 gDp-3-G: 150.7 ± 8.6–288.5 ± 8.1 mg/100 g
(65)

      

      




Dp-3-R: 213.9 ± 12.9–369.3 ± 2.6 mg/100 gFraction 5Anthocyanin: 513.7 ± 26.4–911.7 ± 13.1 mg/100gDp-3-G: 133.1 ± 5.9–249.9 ± 7.6Dp-3-R: 191.4 ± 13.2–320.2 ± 1.3


      

      
10
Blackcurrant (Ribes nigrum L.) pomace
Extraction with acidified water (0.01% v/v concentrated HCl) and purification with Amberlite XAD-7HP resin and elution with acidified ethanol (0.01% v/v conc. HCl). Further extraction with acidified water, isopropylacetate and ethyl acetate
HPLC conditions column: Zorbax Eclipse XDB C18 (150 × 4.6 mm, 5 μm)Flow rate: 1 mL/minInjection volume: 10 μLMobile phase A: water (0.5% TFA)Mobile phase B: acetonitrile (0.5% TFA)DAD wavelength: 190–600 nm and for anthocyanin-520 nmPreparative HPLC conditions column: XBridge Prep C18 (10 × 50, 5 μm)Flow rate: 5 mL/minInjection volume: 300 μLRest conditions were similar to analytical HPLC
Concentration of Dp-3-R (22.6%) was highest followed by Cy-3-R (20.4%), Dp-3-G (7.7%), Cy-3-G (4%)
(66)

      

      
11
Eggplant (Solanum melongena L)
Sadilova et al. reported the extraction from eggplant peel with aqueous acetone maintained at pH 1 i.e., water acidified with trifluoroacetic acid/acetone, 30:70, v/vSolvent assisted extraction employing methanol with 3% trifluoroacetic acidDranca et al. reported the ultrasound assisted extraction from eggplant peel with frequency of 12.5, 25, and 37.5 KHz at temperature of 50, 60 and 70°C with extraction time of 15, 30, and 45 min and employing solvents methanol and 2-propanol
HPLC conditions column: C18 sunfire column, Waters (250 × 4.6 mm, 5 μm) and a C18 pre-column, Phenomenex (4 × 3.0 mm i.d.)Column temperature: 25°CFlow rate: 1 mL/minMobile phase A: 5% formic acid solutionMobile phase B: 100% acetonitrileDAD wavelength: 520 nm
Dp-3-R: 378 ± 9.9 mg/kgDp-3-G: 16.5 ± 1.0 mg/kgDp-3-R-5G: 36.5 ± 0.8 mg/kgDp-3-R-G: 19.1 ± 0.1 mg/kg.
(67, 68)

      

      
12
Violet pepper (Capsicum annuum L.) peel
Extraction from voilet pepper peel with aqueous acetone maintained at pH 1 i.e., water acidified with trifluoroacetic acid/acetone, 30: 70, v/vSolvent assisted extraction employing methanol with 3% trifluoroacetic acid
HPLC conditions column: C18 sunfire column, Waters (250 × 4.6 mm, 5 μm) and a C18 pre-column, Phenomenex (4 × 3.0 mm i.d.)Column temperature: 25°CFlow rate: 1 mL/minMobile phase A: 5% formic acid solutionMobile phase B: 100% acetonitrileDAD wavelength: 520 nm Characterization was further done by ESI-MS
Dp-3-R-5-G: 36.5 ± 0.8 mg/kgDp-3-G: 2.2 ± 0.0 mg/kgDp-3-R: 2.9 ± 0.2 mg/kgDp-3-rhamnoside: 2.4 ± 0.5 mg/kgDp-3-caffeoyl-rutinoside-5-G: 7.8 ± 0.4 mg/kgDp-3-cis-coumaroyl-rutinoside-5-G: 14.7 ± 0.8 mg/kgDp-3-trans-coumaroyl-rutinoside-5-G: 286.2 ± 1.7 mg/kgDp-3-feruloyl-rutinoside-5-hexose: 3.8 ± 0.1 mg/kg
(67)

      

      
13
Hibiscus sabdariffa (Roselle)
Solvent-aided extraction from Hibiscus sabdariffa dried calyces using distilled water as a solvent
HPLC conditions column: Phenomenex Gemini C18 column (250 × 4.6 mm, 5 μm)Column temperature: 35°CFlow rate: 1 mL/minInjection volume: 10 μlMobile phase A: 0.1% (v/v) trifluoroacetic acidMobile phase B: trifluoroacetic acid/acetonitrile/water (50:49.9:0.1)DAD wavelength: 265–520 nm
Dark red varietyAnthocyanin: 2,732 ± 260 mg/100 gDp-3-S: 2,116 ± 216 mg/100 gDp-3-G: 76 ± 8 mg/100 gLight red varietyAnthocyanin: 727 ± 55 mg/100 gDp-3-S: 535 ± 37 mg/100 gDp-3-G: 38 ± 1 mg/100 g
(18)

      
      

      
      

Pharmacokinetic (Absorption, Distribution, Metabolism, and Excretion) Profile of Dp

      Absorption and metabolism of anthocyanins rely on aglycones and type of sugar moiety present (69). Bioavailability of Dp is mainly governed by the type of sugar moiety present and its metabolism. A galactoside moiety possessed the highest bioavailability followed by glucoside and arabinoside (70). Dp-3R and Dp-3G are absorbed, distributed, and excreted in intact form along with the sugar moiety. Minor amounts of the metabolite 4′-O-methyl-Dp-3R were also excreted in urine. Bioavailability of orally administered Dp-3R is very poor, i.e., 0.49 ± 0.06% and 0.5% for oral and IV administration, respectively. Plasma Cmax value is maximum for anthocyanins with rutinoside moiety (71–73). Dp-3G is absorbed in intact form and appears in the blood plasma 15 min after oral administration, and another absorption peak is seen after 60 min. Dp-3G is metabolized by methylation of the 4′ OH group in B-ring by COMT, and the metabolite exhibits better distribution profile (74). Dp-3G gets absorbed in the stomach and upper part of the small intestine because of bacteria and enzymes in the small intestine and partly because of early methylation of the glucoside (75). Intake of carbohydrate rich diet, delayed absorption and excretion of Dp-3R and Dp-3G in blackcurrant is due to longer transit time in GIT (76). Gallic acid is expected to be a major product of Dp-3G metabolism, but the literature by Nurmi et al. revealed that no gallic acid metabolite was observed in human urine although other metabolites were detected (77). Another study illustrated that Dp is unstable in its aglycone form, and that it has a half-life of <30 min. LC-MS/MS data manifested that Dp (aglycone), within 30 min, was rapidly converted into gallic acid and 2,4,6-trihydroxybenzaldehyde (78). The Dp present in blueberry and Kenyan purple tea crossed the blood-brain barrier and reached the central nervous system (CNS) in its intact glycosidic form. Availability of Dp was low in the CNS compared to other anthocyanins because of lower logP-value (79, 80). A bioavailability study conducted on Delphinol® (powder extract of maqui berry) showed that Dp-3G could only reach a concentration of 0.64 μg/ml in the systemic circulation of human healthy volunteers, and that its maximum concentration was observed at 1 ± 0.3 h. Cmax values ranged from 21.39 to 63.55 nmol/L (81).
      

      Dp glycosides such as Dp-3G, Dp-3R, Dp-3-Gal, and Dp-3-Ar, are comparatively more bioavailable than Dp, which suffers from low bioavailability owing to its poor aqueous solubility (82). Bioavailability of Dp glycosides was found in the following order: Dp-3-Gal (0.48%) > Dp-3G (0.14%) ~ Dp-3-Ar (0.14%).
      

      The low bioavailability, instability in physiologic pH, and high reactivity of Dp pose major challenges to the scientific community. Various approaches have been tried to improve the bioavailability of Dp so this naturally occurring plant pigment can find applications as a dietary supplement and nutraceutical in the food and pharmaceutical industries. Attempts have been made to improve its solubility, stability, and bioavailability by complexation with cyclodextrins such as sulfobutylether-β-cyclodextrin (83), microencapsulation with natural polymers, multiple emulsions, and nanoformulations (84–86). Dp nanoliposomes prepared by mingling cholesterol with a dried lipid layer of soy lecithin was better in reducing albumin glycation (91.5%) than Dp (69.5%) (87).
      

Metabolic Characteristics of Dp and Its Effect on Gut Microbiota

      Anthocyanins and anthocyanidins are reported to be absorbed from the intestine after ingestion; they interact with the transport proteins OATP1B1 and OATP1B3 and get transported to the liver for metabolism and excreted in the bile (88). Anthocyanins undergo metabolic biotransformation with the help of catechol-O-methyl transferase (COMT) in the gut and liver. Gut microbiota are mainly responsible for the biotransformation of most dietary anthocyanins that are not absorbed in the upper gastrointestinal tract. Lactobacillus bacteria are primarily involved in the metabolism of Dp in the colon. They use intestinal gut enzymes, like glucosidase, glucuronidase, galactosidase, and rhamnosidase, to cleave the glycosidic bond of Dp glycosides (anthocyanin) and to set the aglycone (anthocyanidin) part free. Gut microbiota allow the absorption of Dp and other flavonoids, and enhance their bioavailability (89). Pharmacokinetic information on Dp indicated that it reaches peak plasma value after 2 h of ingestion, and that the phase II metabolite of Dp glucuronide reaches peak level after 6.3 h (14). In a tissue culture medium, Dp degrades rapidly with a half-life of ~30 min into gallic acid and phloroglucinol aldehyde. Human primary hepatocytes and liver microsomal enzymes like CYP2C6, CYP2A6, CYP2B6, and CYP3A4 have been used for evaluation of metabolic characteristics of anthocyanins and anthocyanidins (88). It has been noted that Dp at a concentration of 100 μM significantly inhibits 90% of CYP3A4 catalytic activity. Glucosides of Dp inhibit the activity of CYP2C9 by 55%, and Dp-3-rut reduces the activity of CYP3A4 by 35% (90). Dp also inhibits glutathione S transferases (GSTs), carbonyl reductases (CBRs), and UDP-glucuronsyl transferases (UGTs).
      

      Dp was found to possess significant noncompetitive inhibitory effects against human CBRs with an IC50 value of 16 μM and a substrate concentration of 500 μM, and to moderately and mildly inhibit UGTs and GSTs (IC50 = 150 μM), respectively. These inhibitory potencies are significantly different in rat and humans' samples. Differences in the metabolic pathway of Dp and its glucosides have also been reported. Dp 3, 5 di-glucoside can reduce the expression of SLCO/OATP1B3, but this effect has not been reported for Dp, indicating a correlation between the presence and the absence of a sugar moiety. Some factors like oxygen, polyphenols, and metals influence the metabolic degradation pathway of Dp analogs (14).
      

      Consumption of high-fat diet, fruits, and vegetables rich in bioactive phenolic compounds are known to affect the gut microbiome, and significant changes in the population of gut microbiota could either increase or decrease the risk of chronic diseases. The interaction of gut microbiota with anthocyanins plays a prominent role in regulating homeostasis and the prebiotic activity of gut microbiome and its composition and population. One study reported that consumption of berries containing high content of Dp promoted proliferation of an oxygen-sensitive bacterial population by decreasing oxygen tension in gut lumens of mice (91). Igwe et al. carried out a systematic literature review to study the effect of anthocyanins on a population of gut mircobiota by including three in vitro, two in vivo animal model studies and one human interventional study. They concluded that anthocyanins exert beneficial effects on the population of gut microbiota, especially on proliferation of Bifidobacterium spp. and lactobacillus-Enterococcus spp., and on inhibition of a species of pathogenic bacteria, Clostridium histolyticum. Bifidobacterium spp. and lactobacillus spp. are widely used in probiotics to treat irritable bowel syndrome (IBS), enterocolitis, and diarrhea, and to exert beneficial effects on colorectal cancer (92). Dp-3G has been shown to significantly inhibit the population of the C. histolycum group (93). However, only a limited number of in vitro, in vivo, and human studies have been conducted so far; thus, it cannot be generalized that consumption of fruits and vegetables rich in Dp or supplementation with Dp leads to a favorable effect. More detailed animal and human studies are needed to confirm the beneficial effects of consumption of anthocyanin-/anthocyanidin-rich food including Dp on proliferation of healthy anaerobic gut microbiota. Also, the interaction between simultaneously administered drugs and high dose of anthocyanidin dietary supplement should be studied in greater detail to decide for a pharmacotherapeutic treatment plan. Although many reports defined potential interactions between drugs and anthocyanin supplements, their deep molecular metabolic reactions and safety concerns are not well-described; hence further research is warranted in the future.
      

Therapeutic Potential and Health Benefits of Dp

Anticancer Activity

      Dp as both anthocyanidin and anthocyanin exhibits dominant anticancer activity against a variety of cancers such as breast, ovarian, colon, prostate, lung, hepatic, bone, blood, and skin cancers. Data from various literatures highlighting the anticancer potential of Dp and some of its glycosides are presented below. In majority of cancers, Dp acts by interfering with protein targets of the PI3K/Akt/mTOR and MAPK signaling pathways. The plausible mechanism of action of anticancer activity is illustrated in Supplementary Figures 1, 2).
      

Dp in Breast Cancer

      Hepatocyte growth factor (HGF) and Met are potential candidate targets for therapeutic and pharmacological intervention in breast cancer therapy. Pretreatment of the human mammary epithelial cell line (MCF-10A) with Dp (5–40 μM) for 3 h inhibited the stimulation of Met expression. An immunoblot analysis revealed that Dp treatment down-regulated the expression of downstream proteins involved in regulating cell viability stimulated by HGF/Mets like FAK and Src, paxillin, CrkII and CrkL, Gab1, and SHP-2. Dp also prevented phosphorylation of Raf-1, MEK1/2, ERK1/2, STAT3, AKT, mTOR, p70S6K, and eIF4E, and the expression of PI3K85 stimulated by HGF. Consequently, Dp prevented HGF-provoked NF-κB and PKCα signaling (94).
      

      Ozbay and Nahta observed that Dp (12.5, 25, 50, and 100 μg/ml) could induce apoptosis in seven breast cancer cell lines including ER negative (HCC1806, MDA231, MDA468, SKBR3, and MDA453) and ER positive (BT474, MCF7, MCF10A), but that apoptosis was not induced in non-transformed MCF10A cell lines. Rate of apoptosis was noted to be highest in human epidermal growth factor receptor-2 (HER2)-over expressing cell lines SKBR3 and BT474. Dp also prevented anchorage independent growth, proliferation, and metastasis, and further impeded HER2 and extracellular signal-regulated kinases ERK1/2 signaling in triple negative (MDA231 and MDA468) and HER2-overexpressing cell lines. Growth and ERK-1/2 signaling in transformed MCF10A cells were inhibited by Dp at doses of 25 and 50 μg/ml. Combination of Dp with approved drugs targeting HER-2 (Herceptin and lapatinib) was not effective compared to Dp treatment alone on SKBR3 and BT474 (95).
      

      Chen et al. revealed an immense potential of Dp in the treatment of HER2-positive breast cancer cells. Dp was noted to be active against MDA-MB-453 and BT474 cells (IC50 = 40 and 100 μM, respectively), and induced caspase-9 and caspase-3 mediated apoptosis. TEM data showed that increase in Dp concentration reversed 3-methyladenine and Bafilomycin A1-provoked autophagic suppression and enhanced the expression of autophagic proteins (LC3-II, Atg5-Atg12 conjugate). Dp restrained the phosphorylation of p70S6K and eIF4E (proteins involved in mTOR signaling pathway) and played a role in the activation of ULK1 and FOXO3a (involved in LKB1-AMPK signaling pathway) (96).
      

      Matrix metalloproteinase (MMP)-9 is responsible for metastasis of cancer cells. Dp at a concentration of 60 μM could inhibit MMP-9 expression stimulated by phorbol-12-myristate 13-acetate (PMA) in human breast carcinoma cells (MCF-7). Dp treatment inhibited proteins (p38 and JNK) involved in MAPK signaling pathway; it hindered the PMA-induced expression of c-Jun (AP-1 subunit) and p65 (NF-κB subunit), and IκBα degradation, leading to deactivation of nuclear factor-κB (NF-κB) and AP-1 (97).
      

      Interestingly, Dp-3G treatment did not induce cytotoxicity in MCF10A and a human vascular endothelial cell line (EA. hy926), but cytotoxicity was induced to some extent in breast cancer cell lines like MCF-7, MDA-MB-453, and MDA-MB-231 by Dp-3G (0–40 μM). The anticancer effects of Dp-3-G were due to suppression of Akt stimulation and enhanced IRF1 expression which are involved in controlling HOTAIR expression in carcinogen treated MCF10A, other breast cancer cells and in xenografted breast tumor. A ChIP-qPCR analysis showed that treatment with Dp-3G enhanced the binding of IRF1 with HOTAIR promoter in MDA-MB-231 cells. Suppression of IRF1 expression by IRF1 siRNAs (TCanti-IRF1, stimulated HOTAIR expression and reduced the anticancer effects of Dp, signifying that Dp interferes with the regulation of Akt/IRF1/HOTAIR signaling pathway in breast cancer (98).
      

      Han et al. investigated the anticancer potential of orally administered Dp (100 mg/kg/day) in female Sprague-Dawley rats with 1-methyl-1-nitrosourea (MNU)-induced breast cancer. Dp effectively reduced cancer incidence in the experimental animals by 43.7% and significantly decreased the rate of in vitro cell proliferation in MDA-MB-231, MCF-7, and MDA-MB-453 cell lines. The expression of Ki-67 (a nuclear protein that indicates cellular proliferation) and HOTAIR was substantially high in a control group in comparison with a group administered with Dp. Downregulation of HOTAIR and EZH2 and H3K27me3 expression with Dp resulted in upregulation of miR-34a in breast cancer cells and MNU-treated rats (99).
      

Dp in Ovarian Cancer

      Lim et al. studied the role of Dp in ovarian cancer. The results of terminal de-oxynucleotidyl transferase dUTP nick end labeling (TUNEL) assay indicated that treatment with Dp (10 μM) could effectively suppress growth and migration, and that it was able to induce apoptosis in ovarian cancer cell line (ES2). Downstream proteins of the PI3K/AKT and p38 MAPK signaling pathways like AKT, ERK1/2, and JNK were effectively down-regulated, and the expression of proteins like p38 and GSK3b was not affected by Dp treatment (100). They observed synergism between a Dp-PI3K inhibitor (LY294002) and a Dp-p38 MAPK inhibitor (SB203580) against ES2 cells, whereas combination with an ERK1/2 MAPK inhibitor (U0126) was not significant (101). Subsequently, in 2017, their group demonstrated a cytotoxic effect of Dp (10 μM) on ovarian adenocarcinoma cell line (SKOV3), and downregulation of the expression of AKT, p70S6K, and S6 involved in PI3K pathway and proteins involved in MAPK/ERK1/2 and p38 MAPK pathway. It was noted that Dp treatment did not affect JNK expression, but that it enhanced the number of SKOV3 cells in sub-G1 phase and reduced cells in G0/G1 and G2/M phases. Synergism was observed between Dp-UO126 and Dp-LY294002, as the combination averted the proliferation and expression of ERK1/2 and p70S6K in SKOV3 cells more effectively. Combination of Dp-UO126 caused a tremendous increase in necrotic cells by ~886% and increased the number of SKOV3 cells in sub-G1 phase. Dp-LY294002 exhibited enhanced rate of apoptosis, increased the cells in S and G2/M phases compared to Dp alone, whereas combination of Dp-SB203580 was not much effective. These results indicate that Dp acts by inhibiting PI3K/AKT and ERK1/2 MAPK signaling in SKOV3 cells, and that their inhibition leads to both apoptosis and necrosis. The combination of Dp (10 μM) and paclitaxel (20 μM) was proved to be effective against SKOV3 cells compared to paclitaxel alone (102).
      

      Brain-derived neurotrophic factor (BDNF)-treated SKOV3 cells (100 nM for 24 h) led to increased rate of cell growth and metastasis. Dp, at higher doses of 100 and 200 μM for 24 h, averted BDNF-provoked cell growth, and at a dose of 50 and 75 μM prevented the mobility and invasion of SKOV3 cells. Dp also suppressed the expression of BDNF-provoked metastasis-inducing proteins such as MMP9 and MMP2 (102).
      

Dp in Colorectal Cancer

      Treatment of human colon cancer (HCT116) cells with Dp (30–240 μM, 48 h) decreased growth and proliferation, and enhanced apoptosis in a dose-dependent manner (IC50 110 μM). Dp treatment not only cleaved poly(ADP-ribose) polymerase (PARP), it also attenuated the expression of procaspases–3, –8, and –9. It was observed to interfere with proteins involved in modulation of apoptosis, i.e., led to downregulation of Bcl-2 and upregulation of Bax expression. The number of cells in the G2/M phase of cell cycle was increased upon increasing the dose of Dp. Cell cycle arrest in the G2/M phase was due to reduction in expression of cyclin B1 and cycle 2 kinase and enhanced expression of p53 and p21WAF1/Cip1. NF-κB activation was hindered by Dp treatment of HCT116 cells (103).
      

      Aichinger et al. reported that Alternaria mycotoxin alternariol (AOH), Dp, and genistein exhibit cytotoxic effects on HT-29 cells at 25, ≥25, and ≥ 25 μM, respectively. Synergism was observed between AOH and Dp or genistien, as Dp and AOH in combination exhibited greater toxicity toward HT-29 cells (104).
      

      Altertoxin II (ATX-II) is a genotoxic impurity found in a variety of food products and is mainly responsible for DNA damage in colon carcinoma cells. ATX-II-Dp combination at doses ≥ 5 μM exhibited cytotoxicity in colon carcinoma cell line (HT-29). ATX-II (1 μM, 1 h)-provoked genotoxicity in HT-29 cells was successfully averted by Dp treatment at 50 and 100 μM, both in the presence and the absence of formamidopyrimidin-DNA-glycosylase. Dp (1 μM) also relieved oxidative stress because of generation of ROS by ATX-II (10 μM) in HT-29 cells. An LC-MS analysis revealed that Dp, gallic acid, and phloroglucinol aldehyde led to reduction in levels of ATX-II in solvents like PBS and DMEM but not in DMSO, signifying that Dp undergoes pH-mediated degradation (105).
      

      Huang et al. (106) reported that Dp (50 and 100 μM) dose-dependently can reduce the number of colonies that form in soft agar by three cell lines, DLD-1, SW480, and SW620. Dp (100 μM) further reduced the number of attached SW620 cells, inhibited metastasis in DLD-1 and SW480 cells, downregulated the expression of MMP-2, and upregulated the expression of E-cadherin. In DLD-1 cells, Dp inhibited mir-204-3p expression by suppressing the expression of integrins αV and β3, which in turn suppressed FAK phosphorylation (Tyr397), Src phosphorylation (Tyr416), paxillin phosphorylation (Tyr31, Tyr118, and Tyr181), tensin and talin (integrin-associated adaptor proteins), Rac-1, Cdc42, and Rho A. In vivo studies on male Balb/c nude mice confirmed that Dp (100 μM) prevented metastasis in DLD-1 cells (106).
      

      Recently, Zhang et al. reported that antiproliferative effects of Dp on colon cancer cells (HCT116) are due to apoptosis induction by modulation of the JAK/STAT3 and MAPKinase signaling pathways. Dp treatment is also associated with induction of cytochrome C, Caspase- 3, 8, and 9, and pro-apoptotic Bax, and it was found to inhibit anti-apoptotic protein expression (107).
      

Dp in Prostate Cancer

      Jeong et al. (108) evaluated the cytotoxic effects of Dp against various prostate carcinoma cell lines. TUNNEL assay results indicated that Dp (100 μM, 12 h) was ineffective against certain human prostate cancer cells like Du145 and PC3 cells, but that it exhibited a dose-dependent apoptotic effect on LNCaP cells (p-53 positive). Treatment of LNCap cells with Dp led to enhanced expression of caspases-8, cleaved forms of caspases-3,−7, and PARP-1, whereas caspase inhibitors (zVAD and zDQMD) hindered the Dp-provoked reduction in cell viability. Inhibition of HDAC3 involved in transcriptional activities and upsurge in p53 expression by p53 oligomerization seem to play a role in Dp-induced apoptosis. Dp also showed synergistic effects with HDAC inhibitors, TSA, and MS-275 or HDAC3 siRNA by amplifying reduction in cell survival ability and enhancing the expression, acetylation, and oligomerization of p53 and expression of pro-apoptotic proteins p21 and Bax. Stimulation of the expression of wild-type HDAC3 and HDAC3D309A averted the effects of Dp on the expression of p53, p21, and Bax, whereas the C-terminal deletion mutant HDAC3ΔC did not interfere with the effects of Dp. Dp, during a 24-h treatment, stimulated the expression of p21, Bax, and Noxa in plasmid-transfected LNCaP cells, and the expression was reduced by HDAC3 and HDAC3D309A. Stimulation of caspases by Dp treatment resulted in cleavage of HDAC3, which provoked hyperacetylation and oligomerization of p53, and the expression p53 target genes (108). Furthermore, it was suggested that Dp arrests the signaling of β-catenin in PC3 cells (109).
      

Dp in Lung Cancer

      Pal et al. evaluated the potential of Dp in therapy of non-small cell lung cancer (NSCLC). It was found that treatment of EGFR and VEGFR expressing NSCLC (NCI-H441 and SK-MES-1) with Dp (5–60 μM, 3 h) leads to downregulation of EGF- and VEGF-provoked and constitutive EGFR and VEGFR expressions, respectively. Dp, during a course of 48-h treatment, turned down PI3K/Akt signaling, and its downstream targets were activated by EGFR and phosphorylation of ERK1/2, JNK1/2, and p38 in the cell lines. The expression of Cyclin D1, PCNA, and anti-apoptotic proteins like Mcl-1, Bcl2, and Bcl-xL was suppressed, and the expression of pro-apoptotic genes like Bak and Bax was enhanced by Dp treatment. The expression of caspase-9 and−3 and cleavage of PARP were stimulated by Dp. An MTT analysis showed that Dp (5–100 μM, 48 h) reduced cell viability with IC50 values of 55, 58, and 44 μM for A549, SK-MES-1, and NCI-H441 cells, respectively. In vivo studies on male athymic nude mice (4 weeks old) implanted with NCI-H441 or SK-MES-1 cells demonstrated significant decline in tumor cell growth with Dp (1–2 mg) treatment. The expression of proliferation (Ki67 and PCNA) and apoptotic (caspase-3) markers was enhanced, and the expression of VEGF and CD31 was decreased in Dp-treated mice (110). Later on, it was found that Dp (10–40 μM) did not affect the growth and proliferation of lung cancer cell line (A549 or NCI-H460) but averted the CoCl2 (200 μM)- and EGF (20 ng/ml)-provoked expression of hypoxia-inducible factor-1α (HIF-1α) protein without altering the expression of HIF-1β in lung cancer, breast cancer (MCF-7), and prostate cancer (PC3M) cell lines. Rate of inhibition of HIF-1α was highest in A549 cells. RT-PCR revealed that Dp treatment also suppressed CoCl2− and EGF-provoked VEGF (involved in angiogenesis) protein expression and lowered VEGF mRNA levels in all the above-mentioned cell lines. CoCl2− and EGF-provoked hypoxia-response element (HRE) activity was hindered by Dp (10 μM). HIF-1α mRNA levels remained unaltered with Dp treatment, whereas MG132-stimulated HIF-1α was suppressed by Dp, indicating that Dp acts by interfering with the synthetic pathway of HIF-1α in A459 cells. CoCl2 and EGF treatment, within 10 min, led to elevation in the phosphorylation of ERK, PI3K, Akt, and mTOR, and P4-S6K, involved in regulation of HIF-1α expression, was brought down by Dp treatment (111).
      

      Kang et al. showed that the combination of Dp (5 μM) and ionizing radiation (4 Gy/min) have better outcome than either agent alone. Dp exerted its beneficial effects via inducing autophagy and activating JNK/MAPK pathways to enhance apoptotic cell death in human lung cancer cells (A549) (112).
      

Dp in Skin Cancer

      It has been known that cyclooxygenase-2 (COX-2) is an important target for developing anticancer therapy, as it is overexpressed in (abnormal and elevated levels) skin cancer. Pretreatment with Dp (5–20 μM, 1 h) has been found to hinder UVB-provoked COX-2 and prostaglandin E2(PGE2) expression in the JB6P+ epidermal cell line of female ICR mice. However, at this concentration, Dp was not able to affect the survival ability of cells. WBA data revealed that Dp down-regulated the expression of UVB-provoked MAPKK4, JNK, c-Jun, p38, ERK1/2, p90RSK, AP-1, NF-κB, and several downstream substrates of PI3K pathway, but the expression of MAPKK-3/6, and 7, and MEK-1/2 remained unaffected. In vitro and ex vivo kinase analyses proved that Dp inhibited the expression of MAPKK4 and PI3K. Pull-down assays and molecular modeling data revealed that Dp is bound to the ATP binding site of MAPKK4 and PI3K. The ability of Dp to hinder MAPKK4 and PI3K expression is related to downregulation of COX-2 expression in JB6P+ cells (113).
      

      Delphinidin (Dp) (20 or 40 μM) pre-treatment of JB6 P+ cells also inhibits TNF-α and provokes the expression of COX-2 promoter and COX-2. Dp inhibits TNF-α more effectively than other phenolics like resveratrol (40 μM) or gallic acid. Dp (40 μM) treatment led to reduction in the expression of TNF-α-induced downstream kinases involved in COX-2 expression like AP-1 by 82% and NF-kB by 44%, and several upstream kinases like JNK, p38 MAP, Akt, p90RSK, MSK1, and ERK. A pull-down assay demonstrated that Fyn kinase expression was also suppressed by Dp treatment. It was proved that Dp binds with Fyn kinase irrespective of ATP concentration. Molecular docking highlighted the interaction between Dp and Fyn kinase, as Dp forms hydrogen bonds with the side chain of Gln161 and the backbone carbonyl group of Met249 in the SH2 domain, with the backbone carbonyl group of Tyr343 in the catalytic kinase domain, and showed hydrophobic interaction with Ile402 and Met344 of the kinase domain. Dp also suppressed FAK (a Fyn kinase downstream protein) (114).
      

      Kuo et al. demonstrated that treatment of JB6 P+ cells with Dp (5, 10, and 20 μM) for 1, 3, or 5 days can significantly reduce cellular proliferation and enhance cell viability above 50%. Dp pretreatment of JB6 P+ cells led to reduction in TPA-induced anchorage-independent growth by 69.4, 74.4, and 99.4% with increase in concentration of Dp from 5 to 20 μM. Dp enhanced normalized relative luminescence and antioxidant responsive element (ARE)-dependent luciferase activity in a dose-dependent manner. Furthermore, Dp escalated the expression of Nrf2 and its target genes, which, when bound to the ARE region, triggered the expression of the carcinogen-detoxifying phase 2 enzymes HO-1 and NQO1 and the reactive oxygen species (ROS) scavenger SOD1, and led to CpG demethylation in in the Nrf2 promoter. It was suggested that Dp exhibits its activity by lowering the expression of DNMTs (DNMT1 and DNMT3a) and class I and class II HDACs, which further led to decreased CpG methylation (115).
      

Dp in Osteocarcinoma

      The role of Dp has also been investigated in osteocarcinoma. Interestingly, Dp, in a dose-dependent manner, decreased cell viability by arresting the proliferation of osteosarcoma cell (OS) line (U2OS) and by provoking reactive oxygen species (ROS) production. A western blot analysis indicated that Dp also provoked the expression of LC3-II gene, caused degradation of p62 protein, and led to autophagosome formation. Enhanced activity against OS cells was observed on pre-treatment with the combination of Dp and autophagy inhibitors (3-MA and bafilomycin A1). Flow cytometry and a cell cycle analysis showed that Dp treatment enhanced DNA content in the sub-G1 phase and cell number in the G2/M phase along with reduction in cell number in the G0/G1 phase (116).
      

      Delphinidin (Dp) treatment of OS cell lines (U2OS, HOS, and MG-63) reduced the survival ability of U2OS and HOS cells. A colony-forming assay conducted on U2OS and HOS cells revealed that Dp (0.1–10 μM, 7 days) significantly hindered growth and proliferation. Treatment of U2OS and HOS cells with Dp (75 μM, 6–24 h) showed elevation in condensation of nuclear ratio by 48 and 37%, respectively; shrinkage of tumor cells and apoptosis were also observed in a time-dependent manner. The expression of proteins involved in apoptosis, like Bcl-2, was reduced, and the expression of Bak, pro-caspase-2, and PARP was stimulated, therefore enhancing the release of Cyp c by Dp treatment in OS cell lines. A transwell chamber assay revealed that Dp (75 μM, 24 h) averted metastasis in OS cells. WBA demonstrated that the expression of EMT markers involved in tumor metastasis like E-cadherin was enhanced, while that of N-cadherin, Snail, and Slug was reduced by Dp. The expression of p38 and ERK 1/2 was also hindered by Dp. Dp behaved synergistically with ERK1/2 and p38 inhibitors (SB203580 and PD38059, 20 μM), as co-treatment enhanced the expression of E-cadherin, while that of N-cadherin, Snail and Slug was reduced to a greater extent compared to Dp alone, signifying that Dp prevents metastasis in OS cells by downregulating the ERK/MAPK signaling pathway (117).
      

Dp in Miscellaneous Cancers

      Increased expression of human glyoxalase I (an enzyme involved in detoxification of methylglyoxal, which is highly reactive and involved in apoptosis) has been demonstrated in many tumors such as those of the colon, prostate, and lungs. According to an in vitro GLO I assay, among anthocyanidins, Dp was the most dominant inhibitor of recombinant GLO I, with an IC50 value of 1.9 μM, and 11.7 and 16.4 μM for cyanidin and pelargonidin, respectively. Strong hydrogen bonding was observed between the three hydroxy groups in the B ring of Dp and amino acids (Asn103B, Arg122A, and Arg37B) of GLO I in humans. Dp hindered the growth and proliferation of HL-60 cells in a time-dependent manner at an interval of 24 and 48 h and IC50 values of 80 and 40 μM, respectively. GLO I expression suppressed by Dp led to increase in concentrations of toxic methyl glyoxal, which led to apoptosis (118).
      

      In an interesting study, treatment of human leukemia cell line (HL-60) with Dp at minimal doses resulted in cell death within a 24-h period. However, treatment of hepatocellular carcinoma (HCC) cell lines (SMMC7721, HCCLM3, and MHCC97L) with Dp and Cy3R proved to be insignificant, as Dp was not able to stimulate apoptosis. However, treatment with Dp and Cy3R led to formation of vacuoles within HCC cells, which was related to their free radical scavenging activity and autophagic degradation. Dp was unable to provoke endoplasmic reticulum (ER) stress, as the expression of proteins like ATF-4, CHOP, and Bip remained unaffected. 3-methyladenine- (autophagy inhibitor) and bafilomycin A1-averted Dp stimulated cellular vacuolization, confirming the cause to be autophagic degradation. Results from an immunoblot assay confirmed the enhanced expression of LC3-II protein and supported the fact that Dp can induce autophagy in SMMC7721 cells. Co-treatment with Dp and 3-methyl adenine effectively induced necrosis (50% cell death observed in a 48-h period) in HCC cells, and no caspase activity was recorded, suggesting no apoptotic cell death (119).
      

      Lim et al. investigated the role of Dp in inhibiting EGF-induced epithelial-to-mesenchymal transition (EMT) in HCC. Dp was noted to exhibit dose-dependent anti-proliferative effects against Huh7 and PLC/PRF/5 cells. It also inhibited EGF-induced morphological changes from epithelial to mesenchymal s in HCC primarily by inhibition of EGFR/AKT/ERK signaling pathway (120).
      

      Kang et al. demonstrated the usefulness of Dp in treatment of urinary bladder cancer. Dp showed promising anti-proliferative actions against T24 cell lines. Dp produced a dose-dependent cytotoxic effect (IC50 of 34 μg/ml) by apoptosis induction and ROS generation in cancer cells (121).
      

Synergistic Anticancer Effects of Dp

      Dp acts synergistically with a variety of well-known anticancer agents. Synergistic anticancer effects have been observed with Dp and some drugs. The combination of Dp, cisplatin, and paclitaxel enhanced cytotoxicity by 50%, and Dp also boosted the activity of cisplatin against ES2 cells. The combination of Dp (10 μM) and paclitaxel (20 μM) proved to be more effective against SKOV3 cells than paclitaxel alone (101, 102). Treatment of human glioblastoma cell lines (U87MG and LN18) with Dp (50 μM) alone had minor effect on cell survival ability, whereas synergism was observed in the combination with miR-137. A Matrigel layer assay showed that individually AzaC, Dp, and miR-137 mimics suppressed metastasis and cell invasive ability in U87MG and LN18 cells, and that treatment with miR-137 and, subsequently, with Dp proved to be most significant. A flow cytometric analysis showed that glioblastoma cell lines treated with combination of miR-137 and Dp exhibited characteristic features of apoptotic cells and enhanced expression of annexin V (122, 123). The combination of Dp (8 μM) and As (III) (0–20 μM) resulted in enhanced cytotoxic effects against HL-60 cell lines with reduction in IC50 value from 11.2 to 1.5 μM in HL-60 cells, 2.4 to 1.4 μM in NB4 cells, and 9.9 to 8.2 μM in PMBCs (124). Synergism was also noted in the combination of Dp (0–30 μM, 12 h) and TRAIL (50 ng/ml), as the combination stimulated PARP cleavage in TRAIL-sensitive (Du145) and resistant (LNCaP) cells. The cleavage of caspase-3/7 and expression of caspase-8.9 were enhanced by the combination treatment and, in the presence of zVAD (40 μM), a caspase inhibitor, the apoptotic activity of the combination was significantly reduced. The expression of DR5, BAX, p21, and p53 was enhanced, and the mRNA expression of XIAP, cIAP-2, Bcl-2, survivin, and MCL-1 was decreased by treatment with the combination, whereas inhibition of the expression of DR5 and Bax by siRNA treatment led to aversion of Dp-stimulated TRAIL-provoked caspase-3 activation in LNCap and Du145 cells. HDAC3 (which modulates transcriptional activities and whose inhibition promotes PARP cleavage) expression (confirmed by siRNA inhibition of HDCA3) was suppressed by the combination rather than Dp or TRAIL alone (125).
      

Anti-inflammatory Activity

      Anthocyanins, in particular Dp, possess a broad range of biological activity, especially anti-inflammatory effect. Dp is reported to be a specific histone acetyltransferase (HAT) inhibitor of p300/CBP acetyltransferase and effective in ameliorating symptoms associated with rheumatoid arthritis (RA). It has also been documented that histone deacetylase, histone methyltransferase, and sirtuin 1 activities are unaffected by Dp treatment. Dp, at a high concentration (100 μM), also averted cell viability (30%) in human RA synovial cell line (MH7A), and downregulated the mRNA and protein expressions of NF-κB p65 subunit and decreased cytokine production by inhibiting TNF-α and provoking p65 expression (126).
      

      Dp-3S, a major anthocyanin present in dried calyces of Hibiscus sabdariffa L and Dp (100 μM) were shown to hinder LPS-provoked NO and iNOS production, and expression of inflammatory cytokines like TNF-α, IL-6, and MCP-1 in a dose-dependent manner. Dp (aglycone) exhibited a more prominent activity than Dp-3S and was able to reverse the inflammation caused by NF-κB and MEK/ERK signaling in RAW264.7 cells (20).
      

      Dp is also effective in treatment of spinal cord injury (SCI)-induced inflammation in an SD rat model with depleted Basso, Beattie, Bresnahan (BBB) score. Dp at a dose of 200 mg/kg treatment for 21 days resulted in elevation of BBB scores and subsequent lowering of intramedullary spinal pressure compared to a control group. The anti-inflammatory effects could be due to significant drop in COX-2 and PGE2 level (127).
      

Protection Against Nasal Polyps

      Nasal polyps are non-cancerous benign lesions arising from the mucosa of nasal sinuses or nasal cavity characterized by extracellular matrix (ECM) accumulation. Nasal polyp-derived fibroblast, upon treatment with Dp (0–20 μM), showed suppression of the mRNA expression marker of myofibroblasts (α-SMA) and extracellular matrix proteins (collagen and fibronectin) (128, 129). In human airway epithelial cells, Dp inhibits the expression of MUC8 and MUC5B by acting through toll-like receptor (TLR4)-mediated ERK1/2 and p38 MAPK signaling pathways. Thus, the data support the effectiveness of Dp in the inflammatory airway diseases; therefore, Dp can be considered a promising lead for future research (130).
      

Neuroprotective Activity

      Neurological diseases, specifically Alzheimer's and Parkinson's, are directly correlated to oxidative stress. Dp exhibits neuroprotective activity against hypoxia (14). It has the ability to attenuate the oxidative stress of H2O2 in SK-N-SH cells by inactivation of the ASK-JNK/p38 signaling pathway (14, 131). Dp also showed an effective response by abrogating intracellular calcium influx and tau phosphorylation against cytotoxicity induced by Aβ25−35 (14).
      

      The 3-O-β-galactoside of Dp has the ability to cross the blood-brain barrier (BBB) and its presence was detected in various regions of the brain in experimental animals, indicating its potential in treatment of various disorders related to the brain. Dp, at different concentrations (4, 20, and 100 μg/ml) could attenuate neurotoxicity stimulated by the administration of amyloid beta (Aβ) in PC12 cells. Pretreatment with Dp (20 μg/ml) was also shown to reduce the Aβ-induced stimulation of phosphorylated GSK-3β and tau (elevated levels involved in pathogenesis of Alzheimer's disease) levels (79, 132). Radio ligand binding assays demonstrated that Dp has the potential to bind to human CB1 and CB2 with K1 and K2 value of 21.3 and 34.3 μM, respectively (14).
      

      Treatment with Dp for 25 days in rats with lesions of nucleus basalis of Meynert (NBM) led to normalization of body weight. In a Morris water maze test, Dp-treated rats reached the hidden platform 3 times faster than rats with NBM lesions, signifying better spatial memory, movement control, and cognitive mapping. Furthermore, significant reduction in ROS and AChE activity and levels of amyloid precursor protein (APP) and Aβ protein of rats with NBM lesions was noted after Dp treatment in the hippocampal area. Molecular docking studies confirmed that Dp bound to the active site of AChE and to Aβ protein with a binding energy of −8.11 and −9.43 Kcal/mol, respectively. A decline in deposits of Aβ plaque in Dp-treated rats was also noted because of efficient binding of Dp with the Aβ protein (133).
      

Cardioprotective and Antihypertensive Activity

      Angiotensin-converting enzyme (ACE) is an important component of renin-angiotensin system (RAS), which is involved in regulation of blood pressure. Anthocyanin-rich fractions extracted from Hibiscus sabdariffa hindered ACE activity, with an IC50 value of 91.2 μg/ml. The two major anthocyanins, viz., Dp-3-S and Cy-3-S, were also found to be effective in suppressing ACE activity, with IC50 values of 84.55 ± 2.2 and 68.41 ± 2.87 μg/ml, respectively. A kinetic analysis revealed that the anthocyanin Dp (31.9 μM) was the more effective compound than Cy-3S (56.9 μM), which in turn was more significant than anthocyanin-rich fractions (Ki = 0.065 mg/ml). Dp, because of presence of 3 -OH and Cy with 2 -OH groups in B ring, exhibits prominent interaction with active sites of ACE (134).
      

      Dp, Cy, and quercetin, at a dose of 100 μM, exhibited an ACE inhibitory activity comparable to that of a clinically used ACE inhibitor, captopril (10 μM), in human embryonic kidney (HEK)-293 cells. Pretreatment with Dp, Cy, and quercetin was also able to avert the steroid-induced elevation of ACE levels. RT-qPCR data revealed that the mRNA expression of ACE and renin was suppressed by Dp, Cy, and quercetin, and that captopril enhanced renin mRNA expression. Dp and Cy also inhibited the ACE protein expression in HEK-293 cells. Angiotensin II-provoked AT1R internalization was unaffected by pretreatment with Dp, Cy, and quercetin. On the other hand, losartan inhibited it, signifying that these compounds do not interfere with the angiotensin II receptor (AR) pathway (135).
      

      Administration of Dp (15 mg/kg/day) for a period of 8 weeks in mice was shown to avert cardiac hypertrophy, oxidative stress, and cardiac dysfunction with no signs of toxicity. Furthermore, Dp was noted to reduce myocardial fibrosis and controlled the enhanced mRNA levels of collagen I, collagen III, and connective tissue growth factor (CTGF) in the cardiac extracellular matrix induced by high Ang II levels caused by TAC. Activation of AMPK by Dp led to hindrance in the expression of NOX subunits (p47phox) and, therefore, reduction in Ang II-induced cardiomyocyte hypertrophy. Upregulated levels of Erk1/2, Jnk1/2, and p38 due to TAC were controlled by Dp administration, signifying the role of Dp in MAPK pathway. In aged mice, Dp demonstrated to be effective in reducing the visible characteristics of aging and incidence of cardiac hypertrophy by reduction in superoxide production and NOX activity, and regulation of the AMPK/NOX/MAPK signaling pathway (136).
      

Antidiabetic Activity

      Anthocyanins potentially modulate carbohydrate metabolism and blood glycemic levels, and help reduce many cardiovascular risk factors (137). Dp-3-rutinoside (Dp-3-R) has the ability to increase glucagon-like peptide-1 (GLP-1) secretion in GLUTag cells mediated through the Ca2+/calmodulin-dependent Ca2+-CaMKII pathway. It has been reported that the presence of 3 hydroxyl groups or two methoxyl moieties in the aromatic ring of Dp-3-R is important to stimulate GLP-1 secretion (138). Streptozotocin (STZ)-induced diabetes in mice (male BALB/c), upon treatment with Dp (100 mg/ml), in free and liposomal forms for 8 weeks displayed reduction in albumin glycosylation rate, and the data revealed that the liposomal form of Dp could be developed as an effective treatment modality to control diabetes (87).
      

      Oral pre-administration of black currant extract (5 mg/kg) containing 1 mg Dp-3-R/kg in STZ-induced diabetes in rats showed decrease in blood glucose levels at 30- and 60-min intervals, rise in serum insulin, and elevation in GLP-1 level at 15- and 30-min intervals after IP glucose (2 g/kg) injection. An HPLC analysis revealed that nonsignificant concentrations of Dp-3R degradation products like Dp, gallic acid, and phlorogucinol aldehyde were present in the GI tract. Furthermore, an analysis demonstrated that individual administration of Dp-3R degradation products (Dp, GA, and PGA) was not able to stimulate GLP-1 secretion in GLUTag cells, indicating that the anthocyanin form of Dp-3R present in black currant extract is responsible for controlling blood glucose levels, and that it is not degraded until after 45-60 min of black currant extract administration (139). Furthermore, administration of Dp-3R rich black currant extract along with high sucrose diet for a period of 2–7 weeks to type-2 diabetic mice (male kk-Ay) resulted in significant decrease in serum glucose concentration and increase in basal GLP-1 levels because of enhanced mRNA and protein expression of PC1/3 in the ileum (140).
      

      Human interventional studies also concluded that high doses of anthocyanins have a potential in prevention and management of type 2 diabetes and further warrant deeper analyses to claim their benefits for use in human (137). Dp protected pancreatic beta cells against high glucose-induced injury by increasing the phosphorylation of AMPK alpha: Thre172 stimulated glucose uptake by cells (141). Delphinol®, a product that contains 25% Dp and 35% total anthocyanins, has the ability to decrease post-prandial glucose and insulin in clinical trial. It significantly decreased basal glycemia and insulinemia in a dose-dependent manner, and resulted in improvement in blood glucose level when administered to patients with pre-diabetes (137).
      

Anti-osteoporotic Activity

      Osteoclast precursors (RAW 264.7 cells), upon treatment with anthocyanins (Cy, Dp, and Pg at a dose of 0.25–20 μg/ml) extracted from bilberry and blackcurrant, exhibited significant decrease in RANKL (which stimulates osteoclast formation) expression and osteoclast formation.
      

      In vivo X-ray data highlighted that Dp prevented bone deterioration in ovariectomized female C57BL/6 mice with sRANKL-induced osteoporosis. Dp, at a small dose of 3 mg/kg, inhibited bone resorption, and uterus weight remained unchanged, signifying that Dp acted in a different manner. A TransAM assay proved that Dp and other anthocyanins act by arresting the activation of NF-κB pathway and reducing the expression of c-fos, Nfac, MMP9, and Trap genes involved in the formation of osteoclasts. Dp is reported to be the most potent inhibitor of osteoclast differentiation and considered as an effective agent for preventing bone loss in women with postmenopausal osteoporosis (142).
      

      Dp-3R, isolated from Solanum melongena L., was also reported to enhance the cell viability of an osteoblast precursor cell line (MC3T3-E1). Dp-3-R (10−9 M) increased the expression of Co11A1, ALP, and OC (involved in osteoblast differentiation). Dp-3-R also simulated the expression of β-catenin, showing a positive feedback in the Wnt/β-catenin signaling pathway (143). Another report concluded that Dp possesses an antiproliferative and apoptosis effect in human osteosarcoma HOs and U2OS cells. It has also been highlighted that Dp suppresses cell migration and prevents abrogation of the MAPK signaling pathway (117).
      

      Dp has the ability to activate cytoprotective autophagy in order to protect chondrocytes against H2O2-induced oxidative stress via activation of Nrf2 and NF-KB. Hence, it plays a major role in critical management of osteoarthritis (OA) and helps in preventing the development and progression of OA (144). Pretreatment with Dp-3-O-β-D-glucoside chloride (20 μg/ml) and Dp (20 and 40 μg/ml) has been shown to reduce osteoclast formation in RANKL-treated embryos of medaka (145).
      

Role in Skeletal Muscle Atrophic Activity

      An effect of Dp on muscle atrophy has been reported. Dp has the ability to effectively supress mechanical unloading-induced muscle weight loss. Dp treatment was able to reverse muscle atrophy induced by tail suspension method in C57BL/6 J mice. Dp also prevented the enhanced expression of genes involved in antioxidation, redox regulation, and ROS, ubiquitin ligase, and protein degradation in atrophic mice. Elevated expression of Cbl-b (RING-type ubiquitin ligase, elevated in muscle atrophy) in C2C12 myotubes due to dexamethasone (glucocorticoid) was also controlled by Dp treatment (146). A further study showed that Dp treatment leads to decline in MuRF1 (involved in muscle protein degradation via ubiquitination) mRNA, and protein expression was induced because of dexamethasone treatment in C2C12 cells. It was hypothesized that Dp prevents muscle atrophy by enhancing miR-23a and NFATc3 expression (147).
      

Anti-psoriatic Activity

      Dp at a dose of 80 μM, significantly suppresses the proliferation of normal human epidermal keratinocytes (NHEK) and then initiates apoptosis. However, at a dose of 10–40 μM, Dp did not alter the expression of genes involved in the apoptotic pathway. A 3D epidermal equivalent model showed that Dp treatment enhanced the expression of caspase 14 and keratin 1 (148).
      

      Topical application of Dp (0.5 and 1 mg/cm2 skin area) on psoriasis from lesions present on the flaky skin of mice significantly decreased the lesions and provoked the expression of proteins that are downregulated in psoriasis like caspase-14. Dp-treated mice exhibited reduction in infiltrating macrophages around the epidermis and prevented protein production and mRNA expression of various inflammatory cytokines like TNF-α (149). A 3D human psoriatic skin-equivalent PSE (SOR-300-FT) was treated with Dp for a period of 48–72 h, which resulted in induction of cornification and reduced epidermal thickness with extended treatment (5 days) comparable to vitamin D3 treatment. Levels of pro-inflammatory cytokines like IL-1α, IL-1β, IL-6, IL-8, IL-10, and TNF-α were also decreased by Dp. However, vitamin D3 and retinoic acid only affected IL-1α and IL-1β (150). Histopathological studies demonstrated that Dp decreases acanthosis, epidermal rete ridge projections into the dermis, micro abscesses, and epidermal thickness in imiquimod (IMQ)-treated mice. Dp also impeded the expression of Akt and p70S6K, suggesting the effectiveness of Dp treatment in an IMQ-stimulated psoriasis model (19).
      

      In silico docking studies revealed binding efficiency with PI3Kinases. Dp also exhibited good affinity for p70S6K. Dp was found to interact with rapamycin binding site, FRB of mTOR, with BE-9 kcal/mol better than rapamycin. Dp also attenuates the expression of IL-22 and stimulates the expression of PI3Ks (p110 and p85), Akts (Ser473 and Thr308), mTORs (Ser2448 and Ser2481), PRAS40, and p70S6K (Thr389) (19).
      

Anti-hepatotoxic Activity

      Dp promotes Nrf2 nuclear translocation and leads to increase expression of antioxidant protein HO-1, which is an Nrf2-related phase II enzyme heme oxygenase-I present in HepG2 cells. This confirms the hepatoprotective effect of Dp and its role in regulation of the expression of Nrf2/HO-1 to protect HepG2 cells (151). Dp has been demonstrated to decrease hepatic inflammatory markers such as TNF-α, IL6, and INF. It also decreased the immunopositivity of nuclear factor kappa-B (NF-κB) and CYP2E1 in liver tissues and restored altered hepatic architecture (152). Dp attenuated CCl4-induced hepatotoxicity in Balb/C mice and significantly controlled elevated serum levels of alanine aminotransferase (ALT), aspartate aminotransferase (AST), and alkaline phosphatase (ALP), and improved cleaving cholinesterase (ChE) activity. Increase in liver weight, hydroxyproline content, and oxidative stress (reduced GSH/GSSG ratio) due to CCl4-induced hepatotoxicity was also normalized by Dp. Histopathology studies confirmed that Dp (10 mg/kg)-treated mice have reduced collagen deposits, hepatic lesions, and hepatocyte ballooning, and decreased necrosis compared to a control group. Mice treated with 25 mg/kg treatment showed significant reduction in hepatic fibrosis. The expression of α -SMA (marker for hepatic fibrosis) in activated hepatic stellate cells and the hepatic expression of TNF-α and TGF-β1 were inhibited by Dp treatment, while MMP-9 and metallothionein I/II expression was enhanced by Dp treatment (153).
      

Anti-viral Activity

      Dp is considered as a new inhibitor of hepatitis C virus (HCV) entry in a pangenotypic manner by acting directly on viral particles and impairing their attachment to the surface of cells (154). It also inhibits the expression of viral RNA in a dose-dependent manner (1–10 μM). It has also been observed that Dp acts in early stages of viral infection. Furthermore, an investigation revealed that Dp does not act by interfering with endosomal pH. Dp was also found to be highly virucidal against the DENV-2 and African strains (MR766) of ZIKA virus compared to the American strain (PA259459) (155). Its role in viral replication is considered as a prominent pharmacological action; hence, researchers are using it as a potential lead for the severe acute respiratory syndrome-coronavirus 2 (SARS-CoV2) main protease by computational approaches, especially structure-based virtual (SBV) screening (156). Wu et al. (157) screened 480 bioactive phenolic compounds; among those identified, Cy-3R and Dp-3R were considered as potential inhibitors of RNA-dependent RNA polymerase (RdRp) in SARS-CoV2. In fact, the binding energy of Cy-3R (−107.8 kcal/mol) and Dp-3R (−90.70 kcal/mol) was much better than that of remdesivir (−55.0 kcal/mol) (157).
      

Granted Patents

      Patients has been granted for PD pertaining to innovation in isolation technique and cosmetic and therapeutic uses. Dp is patented to combat melanoma cells, as an immunosuppressant ingredient in formulation, as an anti-infective agent, and for preventing hair loss, etc. Details of various patents granted for Dp are presented in Supplementary Table 1.
      

Summary, Challenges, and Future Delphinidin Research

      Dp is one of the major and bioactive plant pigments with six hydroxy groups present in the flavylium ion. It occurs in both anthocyanin and anthocyanidin forms in berries (blueberry, billberry), concord grapes, blackcurrant, roselle, some tropical fruits, vegetables (eggplant), roots, cereals and wine. Dp (anthocyanidin) is found in nature linked to a variety of sugar moieties, such as glucose, arabinose, galactose, and sambubiose, in the C-3 position (anthocyanin form). Although Dp is more active in its anthocyanidin form, the presence of sugar moiety in the 3rd position in ring C is also vital for its bioavailability. Because of its wide therapeutic spectrum, it has been used along with other nutraceuticals and as a dietary supplement. A brief summary of the reviewed literature in this article highlights the biosynthesis, laboratory synthesis, and stability profiling of Dp. Various glycosides of Dp are extracted in combination with a variety of anthocyanins by a number of extraction and purification techniques; isolation, analysis, and characterization of Dp have been performed using semi-preparative HPLC, UPLC, UV-visible spectroscopy, ESI-MS, IR, and NMR analytical techniques. Several patents have been granted for Dp research that are related to its (i) synthesis, (ii) isolation and analysis, (iii) use in cosmetics, and (iv) therapeutic use as anticancer, antimicrobial, and immunosuppressant, etc. Findings on biosynthetic pathways, chemical synthesis, isolation, and quantitative analysis techniques presented in this review will open pathways and guide researchers to conduct more significant studies on Dp to improve its utility in the cosmetic, food, and pharmaceutical industries.
      

      Dp is highly stable under acidic conditions but unstable under intestinal and neutral pH conditions. Dp, upon thermal degradation and under alkaline stressed conditions, produces gallic acid and phloroglucinaldehyde. Dp suffers from low oral bioavailability compared to other bioactive polyphenolic secondary metabolites such as anthocyanidins and flavonoids. Low bioavailability reduces its clinical utility and, therefore, poses a major challenge to the scientific community. However, efforts have been made to improve its bioavailability as well as stability under alkaline conditions through complexation with cyclodextrins and/or by preparing microencapsulation and nano-formulations for optimized delivery in vivo. Its highly stable analogs prepared by simple substitutions and advanced liposomal delivery protocols are reported to be successful. In spite of these efforts, an ideal Dp formulation with high bioavailability and high stability is not in sight. Another problem with Dp usage is its ability to inhibit CyP450, which increases chances of drug interactions especially in patients taking medications for chronic diseases.
      

      Dp is being recognized as a potent lead in the discovery and development of therapies for treatment of a variety of critical health conditions such as COVID-19. Intensive investigation is ongoing to unlock the hidden potential and diverse biological activities of Dp beyond its usage as a natural pigment, especially the broad spectrum anticancer and antiviral activities. Findings of various studies have demonstrated that Dp in both forms, viz., anthocyanidin and anthocyanin, exhibits promising therapeutic anticancer activity against a variety of cancers such as breast, ovarian, colon, prostate, lung, hepatic, bone, blood, and skin cancers. Furthermore, Dp also exhibits synergistic effects when used in combination with some clinically used anticancer drugs. Recently published studies have also unveiled Dp as a potent cardioprotective agent and very effective against psoriasis, osteoporosis, and a variety of viral species. Some of the mechanisms involve are scavenging of free radicals; interfering with protein targets of the PI3K/Akt/mTOR, MAPK, and ubiquitin-proteasome pathways; lowering the expression of NOX, cytokines, mucins, MMPs, and STATs; inhibiting of ACE; hindering the entry of viral particles; and enhancing the secretion of insulin, GLP-1, LCE3 genes, and certain epidermal proteins. Although the anticancer potential and other useful bioactivities of Dp have been evaluated and well proven in preclinical studies (in vitro experimental studies and in vivo animal studies), there is scarcity of human interventional studies. Preclinical data from these studies are quite encouraging; therefore, this compound deserves further evaluation in clinical trials.
      

      Several studies have also shown Dp to exert beneficial effects on the gut microbiome population. It promoted the proliferation of oxygen-sensitive bacterial population by decreasing oxygen tension in gut lumens. It also significantly enhanced the proliferation of Bifidobacterium spp. and lactobacillus-Enterococcus spp., and inhibited the growth of a species of pathogenic bacteria, Clostridium histolyticum. However, these effects were observed in only few in vivo and small human interventional studies; therefore, it cannot be generalized that supplementation with Dp leads to favorable effects. Hence, there is a need to conduct well designed studies to evaluate the beneficial effects of consumption of anthocyanin-rich food including Dp on the proliferation of healthy anaerobic gut microbiota along with mechanistic studies.
      

      The meticulous investigation of various published literature confirmed the fact that Dp in its anthocyanidin and anthocyanin forms is a promising therapeutic candidate for scientific research beyond nutrition. However, because of lack of proper clinical data, the true potential of Dp is yet to be established.
      

Author Contributions

      AH, SK, UMD, MA, AAA, and AA significantly contributed in the preparation of the manuscript. SK and UMD prepared the figures and tables. AH and SK equally contributed to complete the chemistry part of the manuscript. HC and AA did the revision of the manuscript. All authors read and approved the final manuscript.
      

Funding

      This research study was funded by Institutional Fund Projects under Grant No. IFPRP:578-156-1442. Therefore, the authors gratefully acknowledge the technical and financial support from the Ministry of Education and King Abdulaziz University, Jeddah, Saudi Arabia.
      

Conflict of Interest

      The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
      

Publisher's Note

      All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
      


Supplementary Material

      The Supplementary Material for this article can be found online at: /articles/10.3389/fnut.2022.746881/full#supplementary-material
      
      

References


Cook NC Samman S. Flavonoids—Chemistry, metabolism, cardioprotective effects, dietary sources. J Nutr Biochem. (1996) 7:66–76. 10.1016/0955-2863(95)00168-9



Trauner D. Richard Willstätter and the 1915 nobel prize in chemistry. AngewandteChem Int Ed. (2015) 54:11910–6. 10.1002/anie.20150550726291186


He J Giusti MM. Anthocyanins: natural colorants with health-promoting properties. Ann Rev Food Sci Technol. (2010) 1:163–87. 10.1146/annurev.food.080708.10075422129334


Mazza G Miniati E. Anthocyanins in Fruits, Vegetables and Grains. Boca Raton, FL; Ann Arbor, MI; London, Tokyo: CRC Press (1993)



Ávila M Hidalgo M Sánchez-Moreno C Pelaez C Requena T Pascual-Teresa S. Bioconversion of anthocyanin glycosides by Bifidobacteria and Lactobacillus. Food Res Int. (2009) 42:1453–61. 10.1016/j.foodres.2009.07.026



Fernandes I Faria A Calhau C de Freitas V Mateu N. Bioavailability of anthocyanins and derivatives. J Funct Foods. (2014) 7:54–66. 10.1016/j.jff.2013.05.010



He F Mu L Yan G Liang N Pan Q Wang J . Biosynthesis of anthocyanins and their regulation in colored grapes. Molecules. (2010) 15:9057–91. 10.3390/molecules1512905721150825


Sigurdson GT Tang P Giusti MM. Cis-Trans configuration of coumaric acid acylation affects the spectral and colorimetric properties of anthocyanins. Molecules. (2018) 23:598. 10.3390/molecules2303059829518915


Wang H Nair MG Strasburg GM Chang YC Booren AM Gray JI . Antioxidant and antiinflammatory activities of anthocyanins and their aglycon, cyanidin, from tart cherries. J Nat Prod. (1999) 62:294–6. 10.1021/np980501m10347382


Koide T Kamei H Hashimoto Y Kojima T Hasegawa M. Antitumor effect of hydrolyzed anthocyanin from grape rinds and red rice. Cancer Biother Radiopharm. (1996) 11:273–7. 10.1089/cbr.1996.11.27310851548


Kim SJ Lee HJ Kim BS Lee D Lee SJ Yoo SH . Antiulcer activity of anthocyanins fromrubuscoreanusvia association with regulation of the activity of matrix metalloproteinase-2. J Agric Food Chem. (2011) 59:11786–93. 10.1021/jf104192a21942741


Toufektsian MC de Lorgeril M Nagy N Salen P Donati MB Giordano L . Chronic dietary intake of plant-derived anthocyanins protects the rat heart against ischemia-reperfusion injury. J Nutrition. (2008) 138:747–52. 10.1093/jn/138.4.74718356330


Nizamutdinova IT Jin YC Chung JI Shin SC Lee SJ Seo HG . The anti-diabetic effect of anthocyanins in streptozotocin-induced diabetic rats through glucose transporter 4 regulation and prevention of insulin resistance and pancreatic apoptosis. Mol Nutr Food Res. (2009) 53:1419–29. 10.1002/mnfr.20080052619785000


Chen Z Rui Z Weimei S Linfu L Hai L Zhiping L . The multifunctional benefits of naturally occurring delphinidin and its glycosides. JAgri Food Chem. (2019) 67:11288–306. 10.1021/acs.jafc.9b0507931557009


Fabio G. The Chemistry of Anthocyanins. International Food Information Service. New Hope Network (2005). Available online at: https://www.newhope.com/managing-your-business/chemistry-anthocyanins



Kong JM Chia LS Goh NK Chia TF Brouillard R. Analysis and biological activities of anthocyanins. Phytochemistry. (2003) 64:923–33. 10.1016/S0031-9422(03)00438-214561507


Estévez L Mosquera RA. Molecular structure and antioxidant properties of delphinidin. J Phys Chem A. (2008) 112:10614–23. 10.1021/jp804323718821739


Ifie I Marshall LJ Ho P Williamson G. Hibiscus sabdariffa (Roselle) extracts and wine: phytochemical profile, physicochemical properties, carbohydrase inhibition. J Agric Food Chem. (2016) 64:4921–31. 10.1021/acs.jafc.6b0124627226105


Chamcheu JC Adhami VM Esnault S Sechi M Siddiqui IA Satyshur KA . Dual inhibition of PI3K/Akt and mTOR by the dietary antioxidant, delphinidin, ameliorates psoriatic features in vitro and in an imiquimod-induced psoriasis-like disease in mice. Antioxid Redox Signal. (2017) 26:49–69. 10.1089/ars.2016.676927393705


Sogo T Kumamoto T Ishida H Hisanaga A Sakao K Terahara N . Comparison of the inhibitory effects of delphinidin and its glycosides on cell transformation. Planta Med. (2014) 81:26–31. 10.1055/s-0034-138331125469858


Kumoro AC Retnowati DS Budiyati CS. Solubility of delphinidin in water and various organic solvents between (298.15 and 343.15) k. J Chem Eng Data. (2010) 55:2603–6. 10.1021/je900851k



Noda N Yoshioka S Kishimoto S Nakayama M Douzono M Tanaka Y . Generation of blue chrysanthemums by anthocyanin B-ring hydroxylation and glucosylation and its coloration mechanism. Sci Adv. (2017) 3:e1602785. 10.1126/sciadv.160278528782017


Katsumoto Y Fukuchi-Mizutani M Fukui Y Brugliera F Holton TA Karan M . Engineering of the rose flavonoid biosynthetic pathway successfully generated blue-hued flowers accumulating delphinidin. Plant Cell Physiol. (2007) 48:1589–600. 10.1093/pcp/pcm13117925311


Bu C Zhang Q Zeng J Cao X Hao Z Qiao D . Identification of A novel anthocyanin synthesis pathway in the fungus Aspergillus sydowii H-1. BMC Genomics. (2020) 21:29. 10.1186/s12864-019-6442-231914922


Liu C Yao X Li G Huang L Xie Z. Transcriptomic profiling of purple broccoli reveals light-induced anthocyanin biosynthetic signaling and structural genes. PeerJ. (2020) 8:e8870. 10.7717/peerj.887032411510


Eichenberger M Hansson A Fischer D Dürr L Naesby M. De novo biosynthesis of anthocyanins in Saccharomyces cerevisiae. FEMS Yeast Res. (2018) 18:foy046. 10.1093/femsyr/foy04629771352


Tanaka Y Brugliera F Chandler S. Recent progress of flower colour modification by biotechnology. Int J Mol Sci. (2009) 10:5350–69. 10.3390/ijms1012535020054474


James AM Ma D Mellway R Gesell A Yoshida K Walker V . Poplar MYB115 and MYB134 transcription factors regulate proanthocyanidin synthesis and structure. Plant Physiol. (2017) 174:154–71. 10.1104/pp.16.0196228348066


Jin X Huang H Wang L Sun Y Dai S. Transcriptomics and metabolite analysis reveals the molecular mechanism of anthocyanin biosynthesis branch pathway in different Senecio ruentus cultivars. Front Plant Sci. (2016) 7:1307. 10.3389/fpls.2016.0130727656188


Meanchaipiboon S Kobayashi N Nakatsuka A. Analyses of pigment compositions and anthocyanin biosynthesis gene expression in hirado azalea cultivars. Horticult J. (2020) 89:284–91. 10.2503/hortj.UTD-142



Yang J Shi W Li B Bai Y Hou Z. Preharvest and postharvest UV radiation affected flavonoid metabolism and antioxidant capacity differently in developing blueberries (Vaccinium corymbosum L.). Food Chem. (2019) 301:125248. 10.1016/j.foodchem.2019.12524831377614


Zhang Q Hu J Liu M Shi Y De Vos RCH Ruan J. Stimulated biosynthesis of delphinidin-related anthocyanins in tea shoots reducing the quality of green tea in summer. J Sci Food Agri. (2020) 100:1505–14. 10.1002/jsfa.1015831756273


Pratt DD Robinson R. XXVI.—A synthesis of pyrylium salts of anthocyanidin type. Part V. The synthesis of cyanidin chloride and of delphinidin chloride. J Chem Soc Trans. (1925) 127:166–75. 10.1039/CT9252700166



Bakstad, E,. Method for the Synthesis of Anthocyanins. Available online at: https://patentimages.storage.googleapis.com/92/9e/be/d74eb9d18df575/US8513395.pdf



Thiele W Rothley M Teller N Jung N Bulat B Plaumann D . Delphinidin is a novel inhibitor of lymphangiogenesis but promotes mammary tumor growth and metastasis formation in syngeneic experimental rats. Carcinogenesis. (2013) 34:2804–13. 10.1093/carcin/bgt29123975834


Kraus M Biskup E Richling E Schreier P. Synthesis of [4-14C]-pelargonidin chloride and [4-14C]-delphinidin chloride. J Labelled Comp Radiopharm. (2006) 49:1151–62. 10.1002/jlcr.1120



Ma ZH Li WF Mao J Li W Zuo CW Zhao X . Synthesis of light-inducible and light-independent anthocyanins regulated by specific genes in grape 'Marselan' (V. vinifera L.). PeerJ. (2019) 7:e6521. 10.7717/peerj.652130842905


Wang F Li H Qin Y Mao Y Zhang B Deng Z. Effects of heat, ultrasound, and microwave processing on the stability and antioxidant activity of delphinidin and petunidin. J Food Biochem. (2019) 43:e12818. 10.1111/jfbc.1281831353515


Vidot K Achir N Mertz C Sinela A Rawat N Prades A . Effect of temperature on acidity and hydration equilibrium constants of delphinidin-3-O- and cyanidin-3-O-sambubioside calculated from uni- and multiwavelength spectroscopic data. J Agri Food Chem. (2016) 64:4139–45. 10.1021/acs.jafc.6b0070127124576


Feng J Wu Y Zhang L Li Y Liu S Wang H . Enhanced chemical stability, intestinal absorption, and intracellular antioxidant activity of cyanidin-3-O-glucoside by composite nanogel encapsulation. J Agric Food Chem. (2019) 67:10432–47. 10.1021/acs.jafc.9b0477831466447


Rakic VP Skrt MA Miljkovic MN Kostic DA Sokolovic DT Poklar NE. Effects of pHon the stability of cyanidin and cyanidin 3-o-β-glucopyranoside in aqueous solution. Hem Ind. (2014) 69:511–22. 10.2298/HEMIND140711072R



Chatham LA Howard JE Juvik JA. A natural colorant system from corn: flavone-anthocyanin copigmentation for altered hues and improved shelf life. Food Chem. (2020) 310:125734. 10.1016/j.foodchem.2019.12573431791725


Levy R Okun Z Shpigelman A. the influence of chemical structure and the presence of ascorbic acid on anthocyanins stability and spectral properties in purified model systems. Foods. (2019) 8:207. 10.3390/foods806020731212863


Xue L Wang J Zhao J Zheng Y Wang H Wu X . Study on cyanidin metabolism in petals of pink-flowered strawberry based on transcriptome sequencing and metabolite analysis. BMC Plant Biol. (2019) 19:423. 10.1186/s12870-019-2048-831610785


Castañeda-Ovando A Pacheco-Hernández ML Páez-Hernández ME Rodríguez JA Galán-Vidal CA. Chemical studies of anthocyanins: a review. Food Chem. (2009) 113:859–71. 10.1016/j.foodchem.2008.09.001



Woodward G Kroon P Cassidy A Kay C. Anthocyanin stability and recovery: implications for the analysis of clinical and experimental samples. J Agri Food Chem. (2009) 57:5271–8. 10.1021/jf900602b19435353


Márquez-Rodríguez A Grajeda-Iglesias C Sánchez-Bojorge NA Figueroa-Espinoza MC Rodríguez-Valdez LM Fuentes-Montero M . Theoretical characterization by density functional theory (DFT) of delphinidin 3-O-sambubioside and its esters obtained by chemical lipophilization. Molecules. (2018) 23:1587. 10.3390/molecules2307158729966272


Yang P Yuan C Wang H Han F Liu Y Wang L . Stability of anthocyanins and their degradation products from cabernet sauvignon red wine under gastrointestinal pH and temperature conditions. Molecules. (2018) 23:354. 10.3390/molecules2302035429414926


Ghafoor K AL-Juhaimi FY Choi YH. Supercritical fluid extraction of phenolic compounds and antioxidants from grape (Vitis labrusca B.) Seeds. Plant Foods Hum Nutr. (2012) 67:407–14. 10.1007/s11130-012-0313-122992888


Grajeda-Iglesias C Figueroa-Espinoza MC Barouh N Baréa B Fernandes A de Freitas V . Isolation and characterization of anthocyanins from hibiscus sabdariffa flowers. J Nat Prod. (2016) 79:1709–18. 10.1021/acs.jnatprod.5b0095827312226


Liazid A Guerrero RF Cantos E Palma M Barroso CG. Microwave assisted extraction of anthocyanins from grape skins. Food Chem. (2011) 124:1238–43. 10.1016/j.foodchem.2010.07.05325517342


Paes J Dotta R Barbero GF Martínez J. Extraction of phenolic compounds and anthocyanins from blueberry (Vaccinium myrtillus L.) residues using supercritical CO2 and pressurized liquids. J Supercrit Fluids. (2014) 95:8–16. 10.1016/j.supflu.2014.07.025



Benucci I Río Segade S Cerreti M Giacosa S Paissoni MA Liburdi K . Application of enzyme preparations for extraction of berry skin phenolics in withered winegrapes. Food Chem. (2017) 237:756–65. 10.1016/j.foodchem.2017.06.00328764064


Da Silva LF Guerra CC Klein D Bergold AM. Solid cation exchange phase to remove interfering anthocyanins in the analysis of other bioactive phenols in red wine. Food Chem. (2017) 227:158–65. 10.1016/j.foodchem.2017.01.08728274416


Du Q Jerz G Winterhalter P. Isolation of two anthocyanin sambubiosides from bilberry (Vaccinium myrtillus) by high-speed counter-current chromatography. J Chromatogr A. (2004) 1045:59–63. 10.1016/j.chroma.2004.06.01715378879


Kouakou HT Kouakou LK Décendit A Alain B Da-Costa G Merillon J . Preparative purification of delphinidin 3-0-sambubioside from roselle (Hibiscus sabdariffa L.) petals by fast centrifugation partition chromatography. J Adv Chem. (2010) 6:999–1004. 10.24297/jac.v6i2.2628



Kahkonen MP Heinamaki J Ollilainen V Heinonen M. Berry anthocyanins: isolation, identification and antioxidant activities. J Sci Food Agric. (2003) 83:1403. 10.1002/jsfa.1511



Jordheim M Fossen T Andersen M. Preparative isolation and NMR characterization of carboxypyranoanthocyanins. J Agri Food Chem. (2006) 54:3572–77. 10.1021/jf053240c19127727


Gavrilova V Kajdžanoska M Gjamovski V Stefova M. Separation, characterization and quantification of phenolic compounds in blueberries and red and black currants by HPLC–DAD–ESI-MS. J Agri Food Chem. (2011) 59:4009–18. 10.1021/jf104565y21401099


Müller D Schantz M Richling E. High performance liquid chromatography analysis of anthocyanins in bilberries (Vaccinium myrtillus L.), Blueberries (Vaccinium corymbosum L.), corresponding juices. J Food Sci. (2012) 77:340–5. 10.1111/j.1750-3841.2011.02605.x22394068


Chorfa N Savard S Belkacemi K. An efficient method for high-purity anthocyanin isomers isolation from wild blueberries and their radical scavenging activity. Food Chem. (2016) 197:1226–34. 10.1016/j.foodchem.2015.11.07626675861


Del Bo C Cao Y Roursgaard M Riso P Porrini M Loft S . Anthocyanins and phenolic acids from a wild blueberry (Vaccinium angustifolium) powder counteract lipid accumulation in THP-1-derived macrophages. Euro J Nutr. (2015) 55:171–82. 10.1007/s00394-015-0835-z25595100


Prencipe FP Bruni R Guerrini A Rossi D Benvenuti S Pellati F. Metabolite profiling of polyphenols in Vaccinium berries and determination of their chemopreventive properties. J Pharm Biomed Anal. (2014) 89:257–67. 10.1016/j.jpba.2013.11.01624316426


Yao L Zhang N Wang C Wang C. Highly selective separation and purification of anthocyanins from bilberry based on a macroporous polymeric adsorbent. J Agri Food Chem. (2015) 63:3543–50. 10.1021/jf506107m25786117


Sójka M Król B. Composition of industrial seedless black currant pomace. Eur Food Res Technol. (2008) 228:597–605. 10.1007/s00217-008-0968-x



Farooque S Rose PM Benohoud M Blackburn RS Rayner CM. Enhancing the potential exploitation of food waste: extraction, purification, and characterization of renewable specialty chemicals from blackcurrants (Ribes nigrum L.). J Agri Food Chem. (2018) 66:12265–73. 10.1021/acs.jafc.8b0437330412401


Sadilova E Stintzing FC Carle R. Anthocyanins, colour and antioxidant properties of eggplant (Solanum melongena L.) and violet pepper (Capsicum annuum L.) peel extracts. Zeitschrift Für Naturforschung C. (2006) 61:527–35. 10.1515/znc-2006-7-81016989312


Dranca F Oroian M. Optimization of ultrasound-assisted extraction of total monomeric anthocyanin (TMA) and total phenolic content (TPC) from eggplant (Solanum melongena L.) peel. Ultrason Sonochem. (2016) 31:637–46. 10.1016/j.ultsonch.2015.11.00826701808


Wu X Pittman HE Mckay S Prior RL. Aglycones and sugar moieties alter anthocyanin absorption and metabolism after berry consumption in weanling pigs. J Nutrition. (2005) 135:2417–24. 10.1093/jn/135.10.241716177206


Ichiyanagi T Shida Y Rahman MM Hatano Y Konishi T. Bioavailability and tissue distribution of anthocyanins in bilberry (Vaccinium myrtillus L.) extract in rats. J Agric Food Chem. (2006) 54:6578–87. 10.1021/jf060237016939312


Matsumoto H Inaba H Kishi M Tominaga S Hirayama M Tsuda T. Orally administered delphinidin 3-rutinoside and cyanidin 3-rutinoside are directly absorbed in rats and humans and appear in the blood as the intact forms. J Agric Food Chem. (2001) 49:1546–51. 10.1021/jf001246q11312894


Rechner AR Kuhnle G Hu H Roedig-Penman A van den Braak MH Moore KP . The metabolism of dietary polyphenols and the relevance to circulating levels of conjugated metabolites. Free Rad Res. (2002) 36:1229–41. 10.1080/246-107157602100001647212592675


Matsumoto H Ichiyanagi T Iida H Ito K Tsuda T Hirayama M . Ingested delphinidin-3-rutinoside is primarily excreted to urine as the intact form and to bile as the methylated form in rats. J Agric Food Chem. (2006) 54:578–82. 10.1021/jf052411a16417324


Ichiyanagi T Rahman MM Kashiwada Y Ikeshiro Y Shida Y Hatano Y . Absorption and metabolism of delphinidin 3-O-β-d-glucopyranoside in rats. Free Radical BiolMed. (2004) 36:930–7. 10.1016/j.freeradbiomed.2004.01.00515019977


Jakesevic M Xu J Aaby K Jeppsson B Ahrné S Molin G. Effects of bilberry (Vaccinium myrtillus) in combination with lactic acid bacteria on intestinal oxidative stress induced by ischemia–reperfusion in mouse. J Agric Food Chem. (2013) 61:3468–8. 10.1021/jf400203h23488931


Walton MC Hendriks WH Broomfield AM McGhie TK. Viscous food matrix influences absorption and excretion but not metabolism of blackcurrant anthocyanins in rats. J Food Sci. (2009) 74:H22–9. 10.1111/j.1750-3841.2008.00996.x19200098


Nurmi T Mursu J Heinonen M Nurmi A Hiltunen R Voutilainen S. Metabolism of berry anthocyanins to phenolic acids in humans. J Agri Food Chem. (2009) 57:2274–81. 10.1021/jf803511619231863


Goszcz K Deakin SJ Duthie GG Stewart D Megson IL. Bioavailable concentrations of delphinidin and its metabolite, gallic acid, induce antioxidant protection associated with increased intracellular glutathione in cultured endothelial cells. Oxidat Med Cell Longev. (2017) 2017:1–17. 10.1155/2017/926070129081896


Andres-Lacueva C Shukitt-Hale B Galli RL Jauregui O Lamuela-Raventos RM Joseph JA. Anthocyanins in aged blueberry-fed rats are found centrally and may enhance memory. Nutr Neurosci. (2005) 8:111–20. 10.1080/1028415050007811716053243


Rashid K Wachira FN Nyabuga JN Wanyonyi B Murilla G Isaac AO. Kenyan purple tea anthocyanins ability to cross the blood brain barrier and reinforce brain antioxidant capacity in mice. Nutr Neurosci. (2013) 17:178–85. 10.1179/1476830513Y.000000008123883519


Schön C Wacker R Micka A Steudle J Lang S Bonnländer B. Bioavailability study of maqui berry extract in healthy subjects. Nutrients. (2018) 10:1720. 10.3390/nu1011172030423989


Zhong S Sandhu A Edirisinghe I Burton-Freeman B. Characterization of wild blueberry polyphenols bioavailability and kinetic profile in plasma over 24-h period in human subjects. Mol Nutr Food Res. (2017) 61:1700405. 10.1002/mnfr.20170040528887907


Sauer RS Krummenacher I Bankoglu EE Yang S Oehler B Schöppler F . Stabilization of delphinidin in complex with sulfobutylether-β-cyclodextrin allows for antinociception in inflammatory pain. Antioxid Redox Signal. (2021) 34:1260–79. 10.1089/ars.2019.795732977733


Mahdavi SA Jafari SM Ghorbani M Assadpoor E. Spray-drying microencapsulation of anthocyanins by natural biopolymers: a review. Dry Technol. (2014) 32:509–18. 10.1080/07373937.2013.83956232331692


Akhtar M Murray BS Afeisume EI Khew SH. Encapsulation of flavonoid in multiple emulsion using spinning disc reactor technology. Food Hydrocoll. (2014) 34:62–7. 10.1016/j.foodhyd.2012.12.025



Gunasekaran T Haile T Nigusse T Dhanaraju MD. Nanotechnology: an effective tool for enhancing bioavailability and bioactivity of phytomedicine. Asian Pac J Trop Biomed. (2014) 4:S1–7. 10.12980/APJTB.4.2014C98025183064


Gharib A Faezizadeh Z Godarzee M. Treatment of diabetes in the mouse model by delphinidin and cyanidin hydrochloride in free and liposomal forms. Planta Med. (2013) 79:1599–604. 10.1055/s-0033-135090824108435


Riha J Brenner S Srovnalova A Klameth L Dvorak Z Jager W . Effects of anthocyans on the expression of organic anion transporting polypeptides (slcos/oatps) in primary human hepatocytes. Food Funct. (2015) 6:772–9. 10.1039/C4FO00977K25578040


Eker ME Aaby K Budic-Leto I Brncic SR El SN Karakaya S . A review of factors affecting anthocyanin bioavailability: possible implications for the inter-individual variability. Foods. (2019) 9:2. 10.3390/foods901000231861362


Srovnalova A Svecarova M Zapletalova MK Anzenbacher P Bachleda P Anzenbacherova E . Effects of anthocyanidins and anthocyanins on the expression and catalytic activities of Cyp2a6, Cyp2b6, Cyp2c9, and Cyp3a4 in primary human hepatocytes and human liver microsomes. J Agric Food Chem. (2014) 62:789–97. 10.1021/jf404643w24387788


Overall J Bonney SA Wilson M Beermann III A Grace MH Esposita D . Metabolic effects of berries with structurally diverse anthocyanins. Int J Mol Sci. (2017) 18:422. 10.3390/ijms1802042228212306


Igwe EO Charlton KE Probst YC Kent K Netzel ME. A systematic literature reviewof the effect of anthocyanins on gut microbiotapopulations. J Hum Nutr Diet. (2019) 32:53–62. 10.1111/jhn.1258229984532


Flores G del Castillo MLR Costabile A Klee A Guergoletto KB Gibson GR. In vitro fermentation of anthocyanins encapsulated withcyclodextrins: release, metabolism and influence on gutmicrobiota growth. J Funct Foods. (2015)16:50–7. 10.1016/j.jff.2015.04.022



Syed DN Afaq F Sarfaraz S Khan N Kedlaya R Setaluri V . Delphinidin inhibits cell proliferation and invasion via modulation of met receptor phosphorylation. Toxicol Appl Pharmacol. (2008) 231:52–60. 10.1016/j.taap.2008.03.02318499206


Ozbay T Nahta R. Delphinidin inhibits HER2 and Erk1/2 signaling and suppresses growth of HER2-overexpressing and triple negative breast cancer cell lines. Breast Cancer Basic Clin Res. (2011) 5:143–54. 10.4137/BCBCR.S715621792311


Chen J Zhu Y Zhang W Peng X Zhou J Li F . Delphinidin induced protective autophagy via mTOR pathway suppression and AMPK pathway activation in HER-2 positive breast cancer cells. BMC Cancer. (2018) 18:342. 10.1186/s12885-018-4231-y29587684


Im NK Jang WJ Jeong CH Jeong GS. Delphinidin suppresses PMA-induced MMP-9 expression by blocking the NF-κB activation through MAPK Signaling pathways in MCF-7 human breast carcinoma cells. J Med Food. (2014) 17:855–61. 10.1089/jmf.2013.307725000305


Yang X Luo E Liu X Han B Yu X Peng X. Delphinidin-3-glucoside suppresses breast carcinogenesis by inactivating the Akt/HOTAIR signaling pathway. BMC Cancer. (2016) 16:423. 10.1186/s12885-016-2465-027388461


Han B Peng X Cheng D Zhu Y Du J Li J . Delphinidin suppresses breast carcinogenesis through the HOTAIR/microRNA-34a axis. Cancer Sci. (2019) 110:3089–97. 10.1111/cas.1413331325197


Lim W Song G. Inhibitory effects of delphinidin on the proliferation of ovarian cancer cells via PI3K/AKT and ERK 1/2 MAPK signal transduction. Oncol Lett. (2017) 14:810–8. 10.3892/ol.2017.623228693237


Lim W Jeong W Song G. Delphinidin suppresses proliferation and migration of human ovarian clear cell carcinoma cells through blocking AKT and ERK1/2 MAPK signaling pathways. Mol Cell Endocrinol. (2016) 422:172–81. 10.1016/j.mce.2015.12.01326704080


Lim WC Kim H Kim YJ Park H Song JH Lee KH . Delphinidin inhibits BDNF-induced migration and invasion in SKOV3 ovarian cancer cells. Bioorgan Med Chem Lett. (2017) 27:5337–43. 10.1016/j.bmcl.2017.09.02429122484


Yun JM Afaq F Khan N Mukhtar H. Delphinidin, an anthocyanidin in pigmented fruits and vegetables, induces apoptosis and cell cycle arrest in human colon cancer HCT116 cells. Mol Carcinogen. (2009) 48:260–70. 10.1002/mc.2047718729103


Aichinger G Beisl J Marko D. Genistein and delphinidin antagonize the genotoxic effects of the mycotoxin alternariol in human colon carcinoma cells. Mol Nutr Food Res. (2017) 61:1600462. 10.1002/mnfr.20160046227628123


Aichinger G Puntscher H Beisl J Kütt ML Warth B Marko D. Delphinidin protects colon carcinoma cells against the genotoxic effects of the mycotoxin altertoxin II. Toxicol Lett. (2018) 284:136–42. 10.1016/j.toxlet.2017.12.00229217480


Huang CC Hung CH Hung TW Lin YC Wang CJ Kao SH. Dietary delphinidin inhibits human colorectal cancer metastasis associating with upregulation of miR-204-3p and suppression of the integrin/FAK axis. Sci Rep. (2019) 9:845. 10.1038/s41598-019-55505-z31831830


Zhang Z Pan Y Zhao Y Ren M Li Y Lu G . Delphinidin modulates JAK/STAT3 and MAPKinasesignaling to induce apoptosis in HCT116 cells. Environ Toxicol. (2021) 2021:23152. 10.1002/tox.2315233955636


Jeong MH Ko H Jeon H Sung GJ Park SY Jun WJ . Delphinidin induces apoptosis via cleaved HDAC3-mediated p53 acetylation and oligomerization in prostate cancer cells. Oncotarget. (2016) 7:56767–80. 10.18632/oncotarget.1079027462923


Lee W Yun JM. Suppression of β-catenin signaling pathway in human prostate cancer PC3 cells by delphinidin. J CancerPrev. (2016) 21:110–4. 10.15430/JCP.2016.21.2.11027390740


Pal HC Sharma S Strickland LR Agarwal J Athar M Elmets CA . Delphinidin reduces cell proliferation and induces apoptosis of non-small-cell lung cancer cells by targeting EGFR/VEGFR2 signaling pathways. PLoS ONE. (2013) 8:772–0. 10.1371/journal.pone.007727024124611


Kim MH Jeong YJ Cho HJ Hoe HS Park KK Park YY . Delphinidin inhibits angiogenesis through the suppression of HIF-1α and VEGF expression in A549 lung cancer cells. Oncol Rep. (2016) 37:777–84. 10.3892/or.2016.529627959445


Kang SH Bak DH Chung BY Bai HW Kang BS. Delphinidin enhances radio-therapeutic effects via autophagy induction and JNK/MAPK pathway activation in non-small cell lung cancer. Korean J Physiol Pharmacol. (2020) 24:413–22. 10.4196/kjpp.2020.24.5.41332830148


Kwon JY Lee KW Kim JE Jung SK Kang NJ Hwang MK . Delphinidin suppresses ultraviolet B-induced cyclooxygenases-2 expression through inhibition of MAPKK4 and PI-3 kinase. Carcinogenesis. (2009) 30:1932–40. 10.1093/carcin/bgp21619776176


Hwang MK Kang NJ Heo YS Lee KW Lee HJ. Fyn kinase is a direct molecular target of delphinidin for the inhibition of cyclooxygenase-2 expression induced by tumor necrosis factor-α. Biochem Pharmacol. (2009) 77:1213–22. 10.1016/j.bcp.2008.12.02119174152


Kuo HCD Wu R Li S Yang AY Kong AN. Anthocyanin delphinidin prevents neoplastic transformation of mouse skin JB6 P+ cells: epigenetic re-activation of Nrf2-ARE pathway. AAPS J. (2019) 21:83. 10.1208/s12248-019-0355-531254216


Lee DY Park YJ Hwang SC Kim KD Moon DK Kim DH. Cytotoxic effects of delphinidin in human osteosarcoma cells. Acta Orthop Traumatol Turc. (2018) 52:58–64. 10.1016/j.aott.2017.11.01129290536


Kang HM Park BS Kang HK Park HR Yu SB Kim IR. Delphinidin induces apoptosis and inhibits epithelial-to-mesenchymal transition via the ERK/p38 MAPK-signaling pathway in human osteosarcoma cell lines. Environ Toxicol. (2018) 33:640–9. 10.1002/tox.2254829451351


Takasawa R Saeki K Tao A Yoshimori A Uchiro H Fujiwara M . Delphinidin, a dietary anthocyanidin in berry fruits, inhibits human glyoxalase I. Bioorg Med Chem. (2010) 18:7029–33. 10.1016/j.bmc.2010.08.01220801663


Feng R Wang SY Shi YH Fan J Yin XM. Delphinidin induces necrosis in hepatocellular carcinoma cells in the presence of 3-methyladenine, an autophagy inhibitor. J Agric Food Chem. (2010) 58:3957–64. 10.1021/jf902545820025272


Lim WC Kim H Ko H. Delphinidin inhibits epidermal growth factor-induced epithelial-to-mesenchymal transition in hepatocellular carcinoma cells. J Cell Biochem. (2019) 120:9887–99. 10.1002/jcb.2827130537288


Kang Y Li J Jing L Zhang Y Wang X. Antiproliferative and apoptosis inducing effect of delphinidin against human bladder cancer cell line. Phcog Mag. (2021) 17:101–5. 10.4103/pm.pm_548_19



Hanif F Muzaffar K Perveen K Malhi SM Simjee ShU. Glioblastoma multiforme: A review of its epidemiology and pathogenesis through clinical presentation and treatment. Asian Pac J Cancer Prev. (2017) 18:3–9. 10.22034/APJCP.2017.18.1.328239999


Chakrabarti M Ray SK. Direct transfection of miR-137 mimics is more effective than DNA demethylation of miR-137 promoter to augment anti-tumor mechanisms of delphinidin in human glioblastoma U87MG and LN18 cells. Gene. (2015) 573:141–52. 10.1016/j.gene.2015.07.03426187071


Yoshino Y Yuan B Okusumi S Aoyama R Murota R Kikuchi H . Enhanced cytotoxic effects of arsenite in combination with anthocyanidin compound, delphinidin, against a human leukemia cell line, HL-60. Chem Biol Interact. (2018) 294:9–17. 10.1016/j.cbi.2018.08.00830125548


Ko H Jeong MH Jeon H Sung GJ So Y Kim I . Delphinidin sensitizes prostate cancer cells to TRAIL-induced apoptosis, by inducing DR5 and causing caspase-mediated HDAC3 cleavage. Oncotarget. (2015) 6:9970–84. 10.18632/oncotarget.366725991668


Seong AR Yoo JY Choi K Lee MH Lee YH Lee J . Delphinidin, a specific inhibitor of histone acetyltransferase, suppresses inflammatory signaling via prevention of NF-κB acetylation in fibroblast-like synoviocyte MH7A cells. Biochem Biophys Res Commun. (2011) 410:581–6. 10.1016/j.bbrc.2011.06.02921683061


Wang CH Zhu LL Ju KF Liu JL Li KP. Anti-inflammatory effect of delphinidin on intramedullary spinal pressure in a spinal cord injury rat model. Exper Ther Med. (2017) 14:5583–8. 10.3892/etm.2017.520629285096


Newton JR Ah-See KW. A review of nasal polyposis. Ther Clin Risk Manag. (2008) 4:507–12. 10.2147/tcrm.s237918728843


Cho JS Kang JH Shin JM Park IH Lee HM. Inhibitory effect of delphinidin on extracellular matrix production via the MAPK/NF-κB pathway in nasal polyp-derived fibroblasts. Allergy Asthma Immunol Res. (2015) 7:276–82. 10.4168/aair.2015.7.3.27625749779


Bae CH Jeon BS Choi YS Song SY Kim YD. Delphinidin inhibits LPS-induced MUC8 and MUC5B expression through toll-like receptor 4-mediated ERK1/2 and p38 MAPK in human airway epithelial cells. Clin Exp Otorhinolaryngol. (2014) 7:198–204. 10.3342/ceo.2014.7.3.19825177436


Kim SM Chung MJ Ha TJ Choi HN Jang SJ Kim SO . Neuroprotective effects of black soybean anthocyanins via inactivation of Ask1-Jnk/P38 pathways and mobilization of cellular sialic acids. Life Sci. (2012) 90:874–82. 10.1016/j.lfs.2012.04.02522575822


Kim HS Sul D Lim JY Lee D Joo SS Hwang KW . Delphinidin ameliorates beta-amyloid-induced neurotoxicity by inhibiting calcium influx and tau hyperphosphorylation. Biosci Biotechnol Biochem. (2009) 73:1685–9. 10.1271/bbb.9003219584523


Heysieattalab S Sadeghi L. Effects of delphinidin on pathophysiological signs of nucleus basalis of meynert lesioned rats as animal model of alzheimer disease. Neurochem Res. (2020) 45:1636–46. 10.1007/s11064-020-03027-w32297026


Ojeda D Jiménez-Ferrer E Zamilpa A Herrera-Arellano A Tortoriello J Alvarez L. Inhibition of angiotensin convertin enzyme (ACE) activity by the anthocyanins delphinidin- and cyanidin-3-O-sambubiosides from Hibiscus sabdariffa. J Ethnopharmacol. (2010) 127:7–10. 10.1016/j.jep.2009.09.05919808084


Parichatikanond W Pinthong D Mangmool S. Blockade of the renin-angiotensin system with delphinidin, cyanin, and quercetin. Planta Med. (2012) 78:1626–32. 10.1055/s-0032-131519822872589


Chen Y Ge Z Huang S Zhou L Zhai C Chen Y . Delphinidin attenuates pathological cardiac hypertrophy via the AMPK/NOX/MAPK signaling pathway. Aging. (2020) 12:5362. 10.18632/aging.10295632209725


Les F Cásedas G Gómez C Moliner C Valero MS López V. The role of anthocyanins as antidiabetic agents: from molecular mechanisms to in vivo and human studies. J Physiol Biochem. (2021) 77:109–31. 10.1007/s13105-020-00739-z32504385


Kato M Tani T Terahara N Tsuda T. The anthocyanin delphinidin 3-rutinoside stimulates glucagon-like peptide-1 secretion in murine GLUTag cell line via the Ca2+/calmodulin-dependent kinase II pathway. PLoS ONE. (2015) 10:126–57. 10.1371/journal.pone.012615725962102


Tani T Nishikawa S Kato M Tsuda T. Delphinidin 3-rutinoside-rich blackcurrant extract ameliorates glucose tolerance by increasing the release of glucagon-like peptide-1 secretion. Food Sci Nutr. (2017) 5:929–33. 10.1002/fsn3.47828748082


Iizuka Y Ozeki A Tani T Tsuda T. Blackcurrant extract ameliorates hyperglycemia in type 2 diabetic mice in association with increased basal secretion of glucagon-like peptide-1 and activation of AMP-activated protein kinase. J Nutr Sci Vitaminol. (2018) 64:258–64. 10.3177/jnsv.64.25830175788


Lai D Huang M Zhao L Tian Y Li Y Liu D . Delphinidin-induced autophagy protects pancreatic β cells against apoptosis resulting from high-glucose stress via AMPKsignaling pathway. Acta Biochim Biophys Sin Shanghai. (2019) 51:1242–9. 10.1093/abbs/gmz12631781740


Moriwaki S Suzuki K Muramatsu M Nomura A Inoue F Into T . Delphinidin, one of the major anthocyanidins, prevents bone loss through the inhibition of excessive osteoclastogenesis in osteoporosis model mice. PLoS ONE. (2014) 9:971–7. 10.1371/journal.pone.009717724824988


Casati L Pagani F Fibiani M Lo Scalzo R Sibilia V. Potential of delphinidin-3-rutinoside extracted from Solanum melongena L. as promoter of osteoblastic MC3T3-E1 function and antagonist of oxidative damage. Euro J Nutr. (2018) 58:1019–32. 10.1007/s00394-018-1618-029372310


Lee DY Park YJ Song MG Kim DR Zada S Kim DH. cytoprotective effects of delphinidin for human chondrocytes against oxidative stress through activation of autophagy. Antioxidants. (2020) 9:83. 10.3390/antiox901008331963866


Imangali N Phan QT Mahady G Winkler C. The dietary anthocyanin delphinidin prevents bone resorption by inhibiting Rankl-induced differentiation of osteoclasts in a medaka (Oryziaslatipes) model of osteoporosis. J Fish Biol. (2020) 98:1018–30. 10.1111/jfb.1431732155282


Murata M Kosaka R Kurihara K Yamashita S Tachibana H. Delphinidin prevents disuse muscle atrophy and reduces stress-related gene expression. Biosci Biotechnol Biochem. (2016) 80:1636–40. 10.1080/09168451.2016.118456027180787


Murata M Nonaka H Komatsu S Goto M Morozumi M Yamada S . Delphinidin prevents muscle atrophy and upregulates miR-23a expression. J Agric Food Chem. (2017) 65:45–50. 10.1021/acs.jafc.6b0366128000445


Chamcheu JC Afaq F Syed DN Siddiqui IA Adhami VM Khan N . Delphinidin, a dietary antioxidant, induces human epidermal keratinocyte differentiation but not apoptosis: studies in submerged and three-dimensional epidermal equivalent models. Exp Dermatol. (2013) 22:342–8. 10.1111/exd.1214023614741


Pal HC Chamcheu JC Adhami VM Wood GS Elmets CA Mukhtar H . Topical application of delphinidin reduces psoriasiform lesions in the flaky skin mouse model by inducing epidermal differentiation and inhibiting inflammation. Br J Dermatol. (2014) 172:354–64. 10.1111/bjd.1351325533330


Chamcheu JC Pal HC Siddiqui IA Adhami VM Ayehunie S Boylan BT . Prodifferentiation, anti-inflammatory and antiproliferative effects of delphinidin, a dietary anthocyanidin, in a full-thickness three-dimensional reconstituted human skin model of psoriasis. Skin Pharmacol Physiol. (2015) 28:177–88. 10.1159/00036844525620035


Xu J Zhang Y Ren G Yang R Chen J Xiang X . Inhibitory effect of delphinidin on oxidative stress induced by H2O2 in HepG2 Cells. Oxid Med Cell Longev. (2020) 2020:4694760. 10.1155/2020/469476033274001


Ezzat SM Salama MM Seif El-Din SH Saleh S El-Lakkany NM Hammam OA . Metabolic profile and hepatoprotective activity of the anthocyanin-rich extract of Hibiscus sabdariffa calyces. Pharm Biol. (2016) 54:3172–81. 10.1080/13880209.2016.121473927564372


Domitrović R Jakovac H. Antifibrotic activity of anthocyanidin delphinidin in carbon tetrachloride-induced hepatotoxicity in mice. Toxicology. (2010) 272:1–10. 10.1016/j.tox.2010.03.01620371262


Calland N Sahuc ME Belouzard S Pène V Bonnafous P Mesalam AA . Polyphenols inhibit hepatitis C virus entry by a new mechanism of action. J Virol. (2015) 89:10053–63. 10.1128/JVI.01473-1526202241


Vázquez-Calvo Á Jiménez de Oya N Martín-Acebes MA Garcia-Moruno E Saiz JC. Antiviral properties of the natural polyphenols delphinidin and epigallocatechin gallate against the flaviviruses West Nile virus, Zika Virus, dengue virus. Front Microbiol. (2017) 8:1314. 10.3389/fmicb.2017.0131428744282


Gahlawat A Kumar N Kumar R Sandhu H Singh IP Singh S . Structure-based virtual screening to discover potential lead molecules for the SARS-CoV-2 main protease. J Chem Inform Model. (2020) 60:5781–93. 10.1021/acs.jcim.0c0054632687345


Wu Y Crich D Pegan SD Lou L Hansen MC Booth C . Polyphenols as potential inhibitors of SARS-CoV-2 RNA dependent RNA polymerase (RdRp). Molecules. (2021) 26:7438. 10.3390/molecules2624743834946521



Abbreviations
ALP

      alkaline phosphatase
      
ALT

      alanine aminotransferase
      
AST

      aspartate aminotransferase
      
AMPK

      AMP-activated protein kinase
      
Bcl2

      B-cell lymphoma 2
      
BE

      binding energy
      
BrdU

      bromodeoxyuridine/5-bromo-2'-deoxyuridine
      
Caspases

      cysteine aspartyl-specific proteases
      
CCK

      8-cell counting kit-8
      
ChE

      cholinesterase
      
COX-2

      cyclooxygenase-2
      
DAD

      diode array detector
      
DCF

      2 Fde array detectorecific prote
      
Dp

      delphinidin
      
ELISA

      enzyme-linked immunosorbent assay
      
EMSA

      electrophoretic mobility shift assay
      
ERKs

      extracellular-signal regulated kinases
      
ESI-MS

      electrospray ionization mass spectrometry
      
FACS

      fluorescence-activated cell sorting
      
GSH

      glutathione
      
GSSG

      oxidized glutathione
      
HDAC

      histone deacetylase
      
HER2

      human epidermal growth factor receptor-2
      
HGF

      hepatocyte growth factor
      
HPLC

      high-performance liquid chromatography
      
IFN-γ

      interferon gamma
      
IL

      interleukin
      
iNOS

      inducible nitric oxide synthase
      
IR

      infrared spectroscopy
      
LPS

      lipopolysaccharide
      
MAPK

      mitogen activated protein kinase
      
MMP

      matrix metalloproteinase
      
MMT- 3-(4, 5-dimethylthiazol-2-yl)-2

      5-diphenyl tetrazolium bromide
      
MTS, [3-(4

      5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium]
      
mTOR

      mammalian target of rapamycin
      
NF-ma

      nuclear factor-t
      
NMR

      nuclear magnetic resonance
      
NOX

      NADPH oxidase
      
OPG

      osteoprotegerin
      
PARP

      poly(ADP-ribose) polymerase
      
PCNA

      proliferating cell nuclear antigen
      
PGE2

      prostaglandin E2
      
PI3K

      phosphoinositide-3 kinase
      
qPCR

      quantitative polymerase chain reaction
      
RANKL

      receptor activator of nuclear factor-nophenyl)
      
ROS

      reactive oxygen species
      
RT-PCR

      reverse transcription polymerase chain reaction
      
SBV

      structure-based virtual screening
      
SRB

      sulforhodamine B
      
STZ

      streptozotocin
      
t-BHP

      tert-butyl hydroperoxide
      
TEM

      transmission electron microscopy
      
TNF-α

      tumor necrosis factor alpha
      
TQ

      triple quaropole
      
TUNNEL

      terminal deoxynucleotidyl transferase dUTP nick end labeling
      
UPLC

      ultra performance liquid chromatography
      
UV

      ultraviolet
      
VEGF

      vascular endothelial growth factor
      
WBA

      Western blot analysis.
      
      
       
      

       

‘Oh, my dear Thomas, you haven’t heard the terrible news then?’ she said. ‘I thought you would be sure to have seen it placarded somewhere. Alice went straight to her room, and I haven’t seen her since, though I repeatedly knocked at the door, which she has locked on the inside, and I’m sure it’s most unnatural of her not to let her own mother comfort her. It all happened in a moment: I have always said those great motor-cars shouldn’t be allowed to career about the streets, especially when they are all paved with cobbles as they are at Easton Haven, which are{331} so slippery when it’s wet. He slipped, and it went over him in a moment.’    My thanks were few and awkward, for there still hung to the missive a basting thread, and it was as warm as a nestling bird. I bent low--everybody was emotional in those days--kissed the fragrant thing, thrust it into my bosom, and blushed worse than Camille.  "What, the Corner House victim? Is that really a fact?" "My dear child, I don't look upon it in that light at all. The child gave our picturesque friend a certain distinction--'My husband is dead, and this is my only child,' and all that sort of thing. It pays in society." leave them on the steps of a foundling asylum in order to insure   [See larger version]    Interoffice guff says you're planning definite moves on your own, J. O., and against some opposition. Is the Colonel so poor or so grasping—or what? Albert could not speak, for he felt as if his brains and teeth were rattling about inside his head. The rest of[Pg 188] the family hunched together by the door, the boys gaping idiotically, the girls in tears. "Now you're married." The host was called in, and unlocked a drawer in which they were deposited. The galleyman, with visible reluctance, arrayed himself in the garments, and he was observed to shudder more than once during the investiture of the dead man's apparel. HoME香京julia种子在线播放
ENTER NUMBET 0016www.hkzttp.com.cn
      
www.mashaike.org.cn
      
www.lhdyf.com.cn
      
www.kk555.com.cn
      
www.lr-ade.com.cn
      
nyd3aily.com.cn
      
rkchain.com.cn
      
poizli.com.cn
      
tgchain.com.cn
      
www.guanggu.org.cn
      
   

      

 
      

      
      

      

      

 
      
处女被大鸡巴操 强奸乱伦小说图片 俄罗斯美女爱爱图 调教强奸学生 亚洲女的穴 夜来香图片大全 美女性强奸电影 手机版色中阁 男性人体艺术素描图 16p成人 欧美性爱360 电影区 亚洲电影 欧美电影 经典三级 偷拍自拍 动漫电影 乱伦电影 变态另类 全部电 类似狠狠鲁的网站 黑吊操白逼图片 韩国黄片种子下载 操逼逼逼逼逼 人妻 小说 p 偷拍10幼女自慰 极品淫水很多 黄色做i爱 日本女人人体电影快播看 大福国小 我爱肏屄美女 mmcrwcom 欧美多人性交图片 肥臀乱伦老头舔阴帝 d09a4343000019c5 西欧人体艺术b xxoo激情短片  未成年人的 插泰国人夭图片 第770弾み1 24p 日本美女性 交动态 eee色播 yantasythunder 操无毛少女屄 亚洲图片你懂的女人 鸡巴插姨娘 特级黄 色大片播 左耳影音先锋 冢本友希全集 日本人体艺术绿色 我爱被舔逼 内射 幼 美阴图 喷水妹子高潮迭起 和后妈 操逼 美女吞鸡巴 鸭个自慰 中国女裸名单 操逼肥臀出水换妻 色站裸体义术 中国行上的漏毛美女叫什么 亚洲妹性交图 欧美美女人裸体人艺照 成人色妹妹直播 WWW_JXCT_COM r日本女人性淫乱 大胆人艺体艺图片 女同接吻av 碰碰哥免费自拍打炮 艳舞写真duppid1 88电影街拍视频 日本自拍做爱qvod 实拍美女性爱组图 少女高清av 浙江真实乱伦迅雷 台湾luanlunxiaoshuo 洛克王国宠物排行榜 皇瑟电影yy频道大全 红孩儿连连看 阴毛摄影 大胆美女写真人体艺术摄影 和风骚三个媳妇在家做爱 性爱办公室高清 18p2p木耳 大波撸影音 大鸡巴插嫩穴小说 一剧不超两个黑人 阿姨诱惑我快播 幼香阁千叶县小学生 少女妇女被狗强奸 曰人体妹妹 十二岁性感幼女 超级乱伦qvod 97爱蜜桃ccc336 日本淫妇阴液 av海量资源999 凤凰影视成仁 辰溪四中艳照门照片 先锋模特裸体展示影片 成人片免费看 自拍百度云 肥白老妇女 女爱人体图片 妈妈一女穴 星野美夏 日本少女dachidu 妹子私处人体图片 yinmindahuitang 舔无毛逼影片快播 田莹疑的裸体照片 三级电影影音先锋02222 妻子被外国老头操 观月雏乃泥鳅 韩国成人偷拍自拍图片 强奸5一9岁幼女小说 汤姆影院av图片 妹妹人艺体图 美女大驱 和女友做爱图片自拍p 绫川まどか在线先锋 那么嫩的逼很少见了 小女孩做爱 处女好逼连连看图图 性感美女在家做爱 近距离抽插骚逼逼 黑屌肏金毛屄 日韩av美少女 看喝尿尿小姐日逼色色色网图片 欧美肛交新视频 美女吃逼逼 av30线上免费 伊人在线三级经典 新视觉影院t6090影院 最新淫色电影网址 天龙影院远古手机版 搞老太影院 插进美女的大屁股里 私人影院加盟费用 www258dd 求一部电影里面有一个二猛哥 深肛交 日本萌妹子人体艺术写真图片 插入屄眼 美女的木奶 中文字幕黄色网址影视先锋 九号女神裸 和骚人妻偷情 和潘晓婷做爱 国模大尺度蜜桃 欧美大逼50p 西西人体成人 李宗瑞继母做爱原图物处理 nianhuawang 男鸡巴的视屏 � 97免费色伦电影 好色网成人 大姨子先锋 淫荡巨乳美女教师妈妈 性nuexiaoshuo WWW36YYYCOM 长春继续给力进屋就操小女儿套干破内射对白淫荡 农夫激情社区 日韩无码bt 欧美美女手掰嫩穴图片 日本援交偷拍自拍 入侵者日本在线播放 亚洲白虎偷拍自拍 常州高见泽日屄 寂寞少妇自卫视频 人体露逼图片 多毛外国老太 变态乱轮手机在线 淫荡妈妈和儿子操逼 伦理片大奶少女 看片神器最新登入地址sqvheqi345com账号群 麻美学姐无头 圣诞老人射小妞和强奸小妞动话片 亚洲AV女老师 先锋影音欧美成人资源 33344iucoom zV天堂电影网 宾馆美女打炮视频 色五月丁香五月magnet 嫂子淫乱小说 张歆艺的老公 吃奶男人视频在线播放 欧美色图男女乱伦 avtt2014ccvom 性插色欲香影院 青青草撸死你青青草 99热久久第一时间 激情套图卡通动漫 幼女裸聊做爱口交 日本女人被强奸乱伦 草榴社区快播 2kkk正在播放兽骑 啊不要人家小穴都湿了 www猎奇影视 A片www245vvcomwwwchnrwhmhzcn 搜索宜春院av wwwsee78co 逼奶鸡巴插 好吊日AV在线视频19gancom 熟女伦乱图片小说 日本免费av无码片在线开苞 鲁大妈撸到爆 裸聊官网 德国熟女xxx 新不夜城论坛首页手机 女虐男网址 男女做爱视频华为网盘 激情午夜天亚洲色图 内裤哥mangent 吉沢明歩制服丝袜WWWHHH710COM 屌逼在线试看 人体艺体阿娇艳照 推荐一个可以免费看片的网站如果被QQ拦截请复制链接在其它浏览器打开xxxyyy5comintr2a2cb551573a2b2e 欧美360精品粉红鲍鱼 教师调教第一页 聚美屋精品图 中韩淫乱群交 俄罗斯撸撸片 把鸡巴插进小姨子的阴道 干干AV成人网 aolasoohpnbcn www84ytom 高清大量潮喷www27dyycom 宝贝开心成人 freefronvideos人母 嫩穴成人网gggg29com 逼着舅妈给我口交肛交彩漫画 欧美色色aV88wwwgangguanscom 老太太操逼自拍视频 777亚洲手机在线播放 有没有夫妻3p小说 色列漫画淫女 午间色站导航 欧美成人处女色大图 童颜巨乳亚洲综合 桃色性欲草 色眯眯射逼 无码中文字幕塞外青楼这是一个 狂日美女老师人妻 爱碰网官网 亚洲图片雅蠛蝶 快播35怎么搜片 2000XXXX电影 新谷露性家庭影院 深深候dvd播放 幼齿用英语怎么说 不雅伦理无需播放器 国外淫荡图片 国外网站幼幼嫩网址 成年人就去色色视频快播 我鲁日日鲁老老老我爱 caoshaonvbi 人体艺术avav 性感性色导航 韩国黄色哥来嫖网站 成人网站美逼 淫荡熟妇自拍 欧美色惰图片 北京空姐透明照 狼堡免费av视频 www776eom 亚洲无码av欧美天堂网男人天堂 欧美激情爆操 a片kk266co 色尼姑成人极速在线视频 国语家庭系列 蒋雯雯 越南伦理 色CC伦理影院手机版 99jbbcom 大鸡巴舅妈 国产偷拍自拍淫荡对话视频 少妇春梦射精 开心激动网 自拍偷牌成人 色桃隐 撸狗网性交视频 淫荡的三位老师 伦理电影wwwqiuxia6commqiuxia6com 怡春院分站 丝袜超短裙露脸迅雷下载 色制服电影院 97超碰好吊色男人 yy6080理论在线宅男日韩福利大全 大嫂丝袜 500人群交手机在线 5sav 偷拍熟女吧 口述我和妹妹的欲望 50p电脑版 wwwavtttcon 3p3com 伦理无码片在线看 欧美成人电影图片岛国性爱伦理电影 先锋影音AV成人欧美 我爱好色 淫电影网 WWW19MMCOM 玛丽罗斯3d同人动画h在线看 动漫女孩裸体 超级丝袜美腿乱伦 1919gogo欣赏 大色逼淫色 www就是撸 激情文学网好骚 A级黄片免费 xedd5com 国内的b是黑的 快播美国成年人片黄 av高跟丝袜视频 上原保奈美巨乳女教师在线观看 校园春色都市激情fefegancom 偷窥自拍XXOO 搜索看马操美女 人本女优视频 日日吧淫淫 人妻巨乳影院 美国女子性爱学校 大肥屁股重口味 啪啪啪啊啊啊不要 操碰 japanfreevideoshome国产 亚州淫荡老熟女人体 伦奸毛片免费在线看 天天影视se 樱桃做爱视频 亚卅av在线视频 x奸小说下载 亚洲色图图片在线 217av天堂网 东方在线撸撸-百度 幼幼丝袜集 灰姑娘的姐姐 青青草在线视频观看对华 86papa路con 亚洲1AV 综合图片2区亚洲 美国美女大逼电影 010插插av成人网站 www色comwww821kxwcom 播乐子成人网免费视频在线观看 大炮撸在线影院 ，www4KkKcom 野花鲁最近30部 wwwCC213wapwww2233ww2download 三客优最新地址 母亲让儿子爽的无码视频 全国黄色片子 欧美色图美国十次 超碰在线直播 性感妖娆操 亚洲肉感熟女色图 a片A毛片管看视频 8vaa褋芯屑 333kk 川岛和津实视频 在线母子乱伦对白 妹妹肥逼五月 亚洲美女自拍 老婆在我面前小说 韩国空姐堪比情趣内衣 干小姐综合 淫妻色五月 添骚穴 WM62COM 23456影视播放器 成人午夜剧场 尼姑福利网 AV区亚洲AV欧美AV512qucomwwwc5508com 经典欧美骚妇 震动棒露出 日韩丝袜美臀巨乳在线 av无限吧看 就去干少妇 色艺无间正面是哪集 校园春色我和老师做爱 漫画夜色 天海丽白色吊带 黄色淫荡性虐小说 午夜高清播放器 文20岁女性荫道口图片 热国产热无码热有码 2015小明发布看看算你色 百度云播影视 美女肏屄屄乱轮小说 家族舔阴AV影片 邪恶在线av有码 父女之交 关于处女破处的三级片 极品护士91在线 欧美虐待女人视频的网站 享受老太太的丝袜 aaazhibuo 8dfvodcom成人 真实自拍足交 群交男女猛插逼 妓女爱爱动态 lin35com是什么网站 abp159 亚洲色图偷拍自拍乱伦熟女抠逼自慰 朝国三级篇 淫三国幻想 免费的av小电影网站 日本阿v视频免费按摩师 av750c0m 黄色片操一下 巨乳少女车震在线观看 操逼 免费 囗述情感一乱伦岳母和女婿 WWW_FAMITSU_COM  偷拍中国少妇在公车被操视频 花也真衣论理电影 大鸡鸡插p洞 新片欧美十八岁美少 进击的巨人神thunderftp 西方美女15p 深圳哪里易找到老女人玩视频 在线成人有声小说 365rrr 女尿图片 我和淫荡的小姨做爱 � 做爱技术体照 淫妇性爱 大学生私拍b 第四射狠狠射小说 色中色成人av社区 和小姨子乱伦肛交 wwwppp62com 俄罗斯巨乳人体艺术 骚逼阿娇 汤芳人体图片大胆 大胆人体艺术bb私处 性感大胸骚货 哪个网站幼女的片多 日本美女本子把 色 五月天 婷婷 快播 美女  美穴艺术 色百合电影导航 大鸡巴用力 孙悟空操美少女战士 狠狠撸美女手掰穴图片 古代女子与兽类交 沙耶香套图 激情成人网区 暴风影音av播放 动漫女孩怎么插第3个 mmmpp44 黑木麻衣无码ed2k 淫荡学姐少妇 乱伦操少女屄 高中性爱故事 骚妹妹爱爱图网 韩国模特剪长发 大鸡巴把我逼日了 中国张柏芝做爱片中国张柏芝做爱片中国张柏芝做爱片中国张柏芝做爱片中国张柏芝做爱片 大胆女人下体艺术图片 789sss 影音先锋在线国内情侣野外性事自拍普通话对白 群撸图库 闪现君打阿乐 ady 小说 插入表妹嫩穴小说 推荐成人资源 网络播放器 成人台 149大胆人体艺术 大屌图片 骚美女成人av 春暖花开春色性吧 女亭婷五月 我上了同桌的姐姐 恋夜秀场主播自慰视频 yzppp 屄茎 操屄女图 美女鲍鱼大特写 淫乱的日本人妻山口玲子 偷拍射精图 性感美女人体艺木图片 种马小说完本 免费电影院 骑士福利导航导航网站 骚老婆足交 国产性爱一级电影 欧美免费成人花花性都 欧美大肥妞性爱视频 家庭乱伦网站快播 偷拍自拍国产毛片 金发美女也用大吊来开包 缔D杏那 yentiyishu人体艺术ytys WWWUUKKMCOM 女人露奶 � 苍井空露逼 老荡妇高跟丝袜足交 偷偷和女友的朋友做爱迅雷 做爱七十二尺 朱丹人体合成 麻腾由纪妃 帅哥撸播种子图 鸡巴插逼动态图片 羙国十次啦中文 WWW137AVCOM 神斗片欧美版华语 有气质女人人休艺术 由美老师放屁电影 欧美女人肉肏图片 白虎种子快播 国产自拍90后女孩 美女在床上疯狂嫩b 饭岛爱最后之作 幼幼强奸摸奶 色97成人动漫 两性性爱打鸡巴插逼 新视觉影院4080青苹果影院 嗯好爽插死我了 阴口艺术照 李宗瑞电影qvod38 爆操舅母 亚洲色图七七影院 被大鸡巴操菊花 怡红院肿么了 成人极品影院删除 欧美性爱大图色图强奸乱 欧美女子与狗随便性交 苍井空的bt种子无码 熟女乱伦长篇小说 大色虫 兽交幼女影音先锋播放 44aad be0ca93900121f9b 先锋天耗ばさ无码 欧毛毛女三级黄色片图 干女人黑木耳照 日本美女少妇嫩逼人体艺术 sesechangchang 色屄屄网 久久撸app下载 色图色噜 美女鸡巴大奶 好吊日在线视频在线观看 透明丝袜脚偷拍自拍 中山怡红院菜单 wcwwwcom下载 骑嫂子 亚洲大色妣 成人故事365ahnet 丝袜家庭教mp4 幼交肛交 妹妹撸撸大妈 日本毛爽 caoprom超碰在email 关于中国古代偷窥的黄片 第一会所老熟女下载 wwwhuangsecome 狼人干综合新地址HD播放 变态儿子强奸乱伦图 强奸电影名字 2wwwer37com 日本毛片基地一亚洲AVmzddcxcn 暗黑圣经仙桃影院 37tpcocn 持月真由xfplay 好吊日在线视频三级网 我爱背入李丽珍 电影师傅床戏在线观看 96插妹妹sexsex88com 豪放家庭在线播放 桃花宝典极夜著豆瓜网 安卓系统播放神器 美美网丝袜诱惑 人人干全免费视频xulawyercn av无插件一本道 全国色五月 操逼电影小说网 good在线wwwyuyuelvcom www18avmmd 撸波波影视无插件 伊人幼女成人电影 会看射的图片 小明插看看 全裸美女扒开粉嫩b 国人自拍性交网站 萝莉白丝足交本子 七草ちとせ巨乳视频 摇摇晃晃的成人电影 兰桂坊成社人区小说www68kqcom 舔阴论坛 久撸客一撸客色国内外成人激情在线 明星门 欧美大胆嫩肉穴爽大片 www牛逼插 性吧星云 少妇性奴的屁眼 人体艺术大胆mscbaidu1imgcn 最新久久色色成人版 l女同在线 小泽玛利亚高潮图片搜索 女性裸b图 肛交bt种子 最热门有声小说 人间添春色 春色猜谜字 樱井莉亚钢管舞视频 小泽玛利亚直美6p 能用的h网 还能看的h网 bl动漫h网 开心五月激 东京热401 男色女色第四色酒色网 怎么下载黄色小说 黄色小说小栽 和谐图城 乐乐影院 色哥导航 特色导航 依依社区 爱窝窝在线 色狼谷成人 91porn 包要你射电影 色色3A丝袜 丝袜妹妹淫网 爱色导航(荐) 好男人激情影院 坏哥哥 第七色 色久久 人格分裂 急先锋 撸撸射中文网 第一会所综合社区 91影院老师机 东方成人激情 怼莪影院吹潮 老鸭窝伊人无码不卡无码一本道 av女柳晶电影 91天生爱风流作品 深爱激情小说私房婷婷网 擼奶av 567pao 里番3d一家人野外 上原在线电影 水岛津实透明丝袜 1314酒色 网旧网俺也去 0855影院 在线无码私人影院 搜索 国产自拍 神马dy888午夜伦理达达兔 农民工黄晓婷 日韩裸体黑丝御姐 屈臣氏的燕窝面膜怎么样つぼみ晶エリーの早漏チ○ポ强化合宿 老熟女人性视频 影音先锋 三上悠亚ol 妹妹影院福利片 hhhhhhhhsxo 午夜天堂热的国产 强奸剧场 全裸香蕉视频无码 亚欧伦理视频 秋霞为什么给封了 日本在线视频空天使 日韩成人aⅴ在线 日本日屌日屄导航视频 在线福利视频 日本推油无码av magnet 在线免费视频 樱井梨吮东 日本一本道在线无码DVD 日本性感诱惑美女做爱阴道流水视频 日本一级av 汤姆avtom在线视频 台湾佬中文娱乐线20 阿v播播下载 橙色影院 奴隶少女护士cg视频 汤姆在线影院无码 偷拍宾馆 业面紧急生级访问 色和尚有线 厕所偷拍一族 av女l 公交色狼优酷视频 裸体视频AV 人与兽肉肉网 董美香ol 花井美纱链接 magnet 西瓜影音 亚洲 自拍 日韩女优欧美激情偷拍自拍 亚洲成年人免费视频 荷兰免费成人电影 深喉呕吐XXⅩX 操石榴在线视频 天天色成人免费视频 314hu四虎 涩久免费视频在线观看 成人电影迅雷下载 能看见整个奶子的香蕉影院 水菜丽百度影音 gwaz079百度云 噜死你们资源站 主播走光视频合集迅雷下载 thumbzilla jappen 精品Av 古川伊织star598在线 假面女皇vip在线视频播放 国产自拍迷情校园 啪啪啪公寓漫画 日本阿AV 黄色手机电影 欧美在线Av影院 华裔电击女神91在线 亚洲欧美专区 1日本1000部免费视频 开放90后 波多野结衣 东方 影院av 页面升级紧急访问每天正常更新 4438Xchengeren 老炮色 a k福利电影 色欲影视色天天视频 高老庄aV 259LUXU-683 magnet 手机在线电影 国产区 欧美激情人人操网 国产 偷拍 直播 日韩 国内外激情在线视频网给 站长统计一本道人妻 光棍影院被封 紫竹铃取汁 ftp 狂插空姐嫩 xfplay 丈夫面前 穿靴子伪街 XXOO视频在线免费 大香蕉道久在线播放 电棒漏电嗨过头 充气娃能看下毛和洞吗 夫妻牲交 福利云点墦 yukun瑟妃 疯狂交换女友 国产自拍26页 腐女资源 百度云 日本DVD高清无码视频 偷拍,自拍AV伦理电影 A片小视频福利站。 大奶肥婆自拍偷拍图片 交配伊甸园 超碰在线视频自拍偷拍国产 小热巴91大神 rctd 045 类似于A片 超美大奶大学生美女直播被男友操 男友问 你的衣服怎么脱掉的 亚洲女与黑人群交视频一 在线黄涩 木内美保步兵番号 鸡巴插入欧美美女的b舒服 激情在线国产自拍日韩欧美 国语福利小视频在线观看 作爱小视颍 潮喷合集丝袜无码mp4 做爱的无码高清视频 牛牛精品 伊aⅤ在线观看 savk12 哥哥搞在线播放 在线电一本道影 一级谍片 250pp亚洲情艺中心,88 欧美一本道九色在线一 wwwseavbacom色av吧 cos美女在线 欧美17,18ⅹⅹⅹ视频 自拍嫩逼 小电影在线观看网站 筱田优 贼 水电工 5358x视频 日本69式视频有码 b雪福利导航 韩国女主播19tvclub在线 操逼清晰视频 丝袜美女国产视频网址导航 水菜丽颜射房间 台湾妹中文娱乐网 风吟岛视频 口交 伦理 日本熟妇色五十路免费视频 A级片互舔 川村真矢Av在线观看 亚洲日韩av 色和尚国产自拍 sea8 mp4 aV天堂2018手机在线 免费版国产偷拍a在线播放 狠狠 婷婷 丁香 小视频福利在线观看平台 思妍白衣小仙女被邻居强上 萝莉自拍有水 4484新视觉 永久发布页 977成人影视在线观看 小清新影院在线观 小鸟酱后丝后入百度云 旋风魅影四级 香蕉影院小黄片免费看 性爱直播磁力链接 小骚逼第一色影院 性交流的视频 小雪小视频bd 小视频TV禁看视频 迷奸AV在线看 nba直播 任你在干线 汤姆影院在线视频国产 624u在线播放 成人 一级a做爰片就在线看狐狸视频 小香蕉AV视频 www182、com 腿模简小育 学生做爱视频 秘密搜查官 快播 成人福利网午夜 一级黄色夫妻录像片 直接看的gav久久播放器 国产自拍400首页 sm老爹影院 谁知道隔壁老王网址在线 综合网 123西瓜影音 米奇丁香 人人澡人人漠大学生 色久悠 夜色视频你今天寂寞了吗? 菲菲影视城美国 被抄的影院 变态另类 欧美 成人 国产偷拍自拍在线小说 不用下载安装就能看的吃男人鸡巴视频 插屄视频 大贯杏里播放 wwwhhh50 233若菜奈央 伦理片天海翼秘密搜查官 大香蕉在线万色屋视频 那种漫画小说你懂的 祥仔电影合集一区 那里可以看澳门皇冠酒店a片 色自啪 亚洲aV电影天堂 谷露影院ar toupaizaixian sexbj。com 毕业生 zaixian mianfei 朝桐光视频 成人短视频在线直接观看 陈美霖 沈阳音乐学院 导航女 www26yjjcom 1大尺度视频 开平虐女视频 菅野雪松协和影视在线视频 华人play在线视频bbb 鸡吧操屄视频 多啪啪免费视频 悠草影院 金兰策划网 (969) 橘佑金短视频 国内一极刺激自拍片 日本制服番号大全magnet 成人动漫母系 电脑怎么清理内存 黄色福利1000 dy88午夜 偷拍中学生洗澡磁力链接 花椒相机福利美女视频 站长推荐磁力下载 mp4 三洞轮流插视频 玉兔miki热舞视频 夜生活小视频 爆乳人妖小视频 国内网红主播自拍福利迅雷下载 不用app的裸裸体美女操逼视频 变态SM影片在线观看 草溜影院元气吧 - 百度 - 百度 波推全套视频 国产双飞集合ftp 日本在线AV网 笔国毛片 神马影院女主播是我的邻居 影音资源 激情乱伦电影 799pao 亚洲第一色第一影院 av视频大香蕉 老梁故事汇希斯莱杰 水中人体磁力链接 下载 大香蕉黄片免费看 济南谭崔 避开屏蔽的岛a片 草破福利 要看大鸡巴操小骚逼的人的视频 黑丝少妇影音先锋 欧美巨乳熟女磁力链接 美国黄网站色大全 伦蕉在线久播 极品女厕沟 激情五月bd韩国电影 混血美女自摸和男友激情啪啪自拍诱人呻吟福利视频 人人摸人人妻做人人看 44kknn 娸娸原网 伊人欧美 恋夜影院视频列表安卓青青 57k影院 如果电话亭 avi 插爆骚女精品自拍 青青草在线免费视频1769TV 令人惹火的邻家美眉 影音先锋 真人妹子被捅动态图 男人女人做完爱视频15 表姐合租两人共处一室晚上她竟爬上了我的床 性爱教学视频 北条麻妃bd在线播放版 国产老师和师生 magnet wwwcctv1024 女神自慰 ftp 女同性恋做激情视频 欧美大胆露阴视频 欧美无码影视 好女色在线观看 后入肥臀18p 百度影视屏福利 厕所超碰视频 强奸mp magnet 欧美妹aⅴ免费线上看 2016年妞干网视频 5手机在线福利 超在线最视频 800av:cOm magnet 欧美性爱免播放器在线播放 91大款肥汤的性感美乳90后邻家美眉趴着窗台后入啪啪 秋霞日本毛片网站 cheng ren 在线视频 上原亚衣肛门无码解禁影音先锋 美脚家庭教师在线播放 尤酷伦理片 熟女性生活视频在线观看 欧美av在线播放喷潮 194avav 凤凰AV成人 - 百度 kbb9999 AV片AV在线AV无码 爱爱视频高清免费观看 黄色男女操b视频 观看 18AV清纯视频在线播放平台 成人性爱视频久久操 女性真人生殖系统双性人视频 下身插入b射精视频 明星潜规测视频 mp4 免賛a片直播绪 国内 自己 偷拍 在线 国内真实偷拍 手机在线 国产主播户外勾在线 三桥杏奈高清无码迅雷下载 2五福电影院凸凹频频 男主拿鱼打女主,高宝宝 色哥午夜影院 川村まや痴汉 草溜影院费全过程免费 淫小弟影院在线视频 laohantuiche 啪啪啪喷潮XXOO视频 青娱乐成人国产 蓝沢润 一本道 亚洲青涩中文欧美 神马影院线理论 米娅卡莉法的av 在线福利65535 欧美粉色在线 欧美性受群交视频1在线播放 极品喷奶熟妇在线播放 变态另类无码福利影院92 天津小姐被偷拍 磁力下载 台湾三级电髟全部 丝袜美腿偷拍自拍 偷拍女生性行为图 妻子的乱伦 白虎少妇 肏婶骚屄 外国大妈会阴照片 美少女操屄图片 妹妹自慰11p 操老熟女的b 361美女人体 360电影院樱桃 爱色妹妹亚洲色图 性交卖淫姿势高清图片一级 欧美一黑对二白 大色网无毛一线天 射小妹网站 寂寞穴 西西人体模特苍井空 操的大白逼吧 骚穴让我操 拉好友干女朋友3p